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Adaptation and Specialization in the Evolution of Bacterial Metabolism 
Abstract 
Specialization is a balance of evolutionary adaptation and its accompanying costs. Here 
we focus on the Lenski Long-Term Evolution Experiment, which has maintained 
cultures of Escherichia coli in the same, defined seasonal environment for 50,000 
generations. This dissertation explores the extent and means by which metabolic 
specialization occurs over an extended period in the same environment.  
Chapter 1 provides an overview and introduction of the problem. 
In Chapter 2 we investigated the acquired dependence on citrate for optimal growth of 
some of the adapting populations. Earlier work uncovered that one of the adapting 
populations gained the ability to utilize citrate as a sole carbon source. We showed that 
in addition to this population, three other lineages evolving in parallel began to rely on 
citrate as a chelator of iron for optimal growth on glucose. This specialization seemed to 
have occurred through loss of function, most consistent with the accumulation of 
mutations in iron transport genes that were obviated by abundant citrate.  
In Chapter 3 we examined changes in fitness of the evolving populations on carbon 
sources other than the glucose on which they adapted. We demonstrated that declines in 
performance were much less widespread than suggested by previous results, and 
surprisingly accompanied by improvements on a variety of substrates. Strains with 
higher mutation rate exhibited significantly more declines, and these were ameliorated 
by growth at lower temperature.  These findings suggested that specialization does not*
* iv 
mainly result as a consequence of adaptive tradeoffs, but rather due to the gradual 
accumulation of disabling mutations in unused portions of the genome. 
In Chapter 4 we tested the ability of Flux Balance Analysis models to predict evolved 
changes in central metabolism. We measured metabolic fluxes for evolved populations 
from the Lenski experiment, and compared them along with datasets from two other 
experiments to flux predictions. We found that improved growth largely derived from 
increased rate of substrate use. Flux predictions were more accurate for two 
experiments initiated with relatively sub-optimal ancestors, whereas ancestors near the 
optimum tended to move away from predictions over experimental evolution. 
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Chapter 1 
Understanding the mechanisms underlying specialization 
Nicholas Leiby1,2 
1 Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, USA, 2 Systems 
Biology Graduate Program, Harvard University, Cambridge, MA, USA 
 
Microbes evolve quickly. To successfully control them in medicine and engineer 
them in industry, we need a predictive understanding of microbial evolution. 
Ideally, we could anticipate the adaptive genetic and phenotypic changes that 
occur in response to a given environment, on what time scale they occur, and 
with what degree of repeatability. 
While the same mutations responsible for adaptive improvement in one 
environment may provide benefit in alternative environments, we do not expect 
this to generally be the case. If there were no cost for improvements, there would 
be a single optimum genotype regardless of environment. Instead we expect 
adaptive improvements to one condition lead to costs in others. These costs may 
result from antagonistic pleiotropy, where the same mutations causing adaptive 
improvements in one environment are harmful in another. Antagonistic 
pleiotropy is also referred to as a tradeoff, and represents a direct cost. Adaptive 
costs may also be a result of mutation accumulation, where mutations with ! 2!
neutral selective effect in the evolutionary environment have a detrimental effect 
in an alternative environment. Mutation accumulation is an opportunity cost- an 
absence of purifying selection resulting in the degradation of unused functions. 
These adaptive costs force organisms into one of two general groups- specialists 
and generalists. Specialists have a high fitness in a narrow range of niches, but 
not necessarily in others. Generalists maintain a moderate level of fitness across a 
broad range of environments. Tradeoffs and mutation accumulation prevent the 
rise of ‘Darwinian Demons’ [1] or super generalists- a single genotype that is 
optimally fit across all environments. These processes are fundamental to 
specialization and the rise and maintenance of global biodiversity. However, the 
relative role and mechanisms of tradeoffs and mutation accumulation are poorly 
understood.  
Our lack of understanding of specialization exists in part because it is challenging 
to study. The relative contributions of natural selection, random events, and 
constraints to adaptation and divergence are not easily separable, and the 
divergence of evolving populations may merely reflect their adaptation to 
different environments. Experiments testing hypotheses about specialization are 
also hampered by the glacial pace of evolution. An ideal model of specialization 
would provide a stable environment to which adaptation can occur, would be 
sufficiently long-running to allow adaptation, and would run in parallel to allow 
the differentiation between chance events and adaptive signal. ! 3!
Fortunately, a model exists that allows us to test fundamental assumptions about 
specialization. In Richard Lenski’s Long-Term Evolution Experiment (LTEE) [2], 
12 parallel populations of Escherichia coli have been passaged daily in minimal 
glucose batch cultures for 26 years and ~58,000 generations of growth. Samples 
were frozen periodically, and they can be revived to study the populations at a 
given time or to rewind and replay evolution (e.g., [3-5]). Fitness of the evolved 
strains in the adaptive environment increased on average by approximately 80% 
in 50,000 generations [6], and the LTEE strains have been evolving in the same 
consistent environment for such a long time that we would expect specialization 
to that environment to have occurred.  
One environmental condition that drives microbial evolution and specialization is 
carbon source availability. In the LTEE, strains were propagated in glucose 
minimal media. One hypothesis is that evolution in this environment would yield 
adaptive improvements to glucose growth resulting in tradeoffs in the ability to 
use other carbon sources. In fact, this has been observed in specific cases, where 
adaptive improvement occurred at the cost of transport of non-glucose sugars 
such as maltose [7], or where portions of the ribose operon were deleted [8].  
A further hypothesis is that the parallel populations will have adapted in parallel 
ways. This has certainly been seen in the LTEE - the populations all improved 
their fitness in the evolutionary environment to similar extents [6]. Many known 
mutations driving the improvements were different between populations, but 
many occurred in more than one population, and at least three occurred in all ! 4!
twelve parallel populations [9], including the above examples of maltose and 
ribose [7,10].  
A previous study attempted to assess the relative roles of mutation accumulation 
and tradeoffs behind the costs of adaptation in the Lenski LTEE [11]. This study 
used an assay of respiration as a proxy for fitness on a wide range of carbon 
sources, and tested performance of the evolved strains at different time points up 
to 20,000 generations. It found that the strains significantly reduced function 
across a wide range of substrates, that these reductions occurred in parallel 
across many or all strains, and that these reductions occurred early on in the 
course of evolution- in the timeframe associated with rapid increases in fitness in 
the evolutionary environment. The authors concluded that these findings were 
most consistent with antagonistic pleiotropy. A further feature of the LTEE 
allowed the authors of this study to assess the extent of costs associated with 
mutation accumulation. A number of the parallel populations had acquired a 
‘mutator’ phenotype caused by mutations to DNA repair genes, causing an 
increase in their mutation rate of approximately 100-fold [11,12]. If mutation 
accumulation played an important role in adaptive costs, it was expected that 
these mutator strains would have reduced catabolic function on more substrates 
than the non-mutators. However, after 20,000 generations, no significant 
differences in functional decreases were observed between the mutators and non-
mutators, and it was concluded that the direct costs of antagonistic pleiotropy 
were the main drivers of adaptive costs [11]. ! 5!
Much has changed in the 13 years since the publication of this previous study. 
One of the LTEE populations acquired the novel ability to catabolize citrate as a 
sole carbon source [13], a finding that made the experiment widely famous. 
Another population was found to harbor a stable phenotypic polymorphism 
maintained in a negative frequency-dependent fashion. One of these 
subpopulations optimized its growth on the glucose in the media, while the other 
became a cross-feeder that cannibalizes resources and lysed cells in stationary 
phase [14-16]. Two more populations acquired the mutator phenotype [3,9], and 
those that were already mutators by the time of the previous study have had 
another 30,000 generations to accumulate mutations.  
This dissertation is a collection of 3 published journal articles that revisit the 
story of specialization in the LTEE. In chapter 3 I examine the roles of mutation 
accumulation and tradeoffs in specialization to the glucose carbon source niche. I 
find that, contrary to previous thinking, the costs of adaptation are driven largely 
by mutation accumulation. In chapter 2 I examine a different form of 
specialization- the narrowing of niche breadth based on an acquired dependence 
to a supplied environmental resource. In chapter 4 I discuss some of the 
underlying physiological changes involved in metabolic adaptation and 
specialization, and test models that attempt to predict these changes. 
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Chapter 2 
Multiple long-term, experimentally-evolved populations of 
Escherichia coli acquire dependence upon citrate as an iron 
chelator for optimal growth on glucose  
Nicholas Leiby1,2, William R. Harcombe2, and Christopher J. Marx2,3,* 
1Systems Biology Graduate Program, Harvard University, Cambridge, MA, USA, 2Department of 
Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, USA, 3Faculty of Arts 
and Sciences Center for Systems Biology, Harvard University, Cambridge, MA, USA.  
*Corresponding Author 
This chapter was originally published in BMC Evolutionary Biology.  I 
performed all of the experiments and analysis for this work, with the exception 
of those for Figure 2.3, which were performed in part by William Harcombe.  I 
was also the primary author of the manuscript.   
Specialization for ecological niches is a balance of evolutionary adaptation and its 
accompanying tradeoffs.  Here we focus on the Lenski Long-Term Evolution 
Experiment, which has maintained cultures of Escherichia coli in the same, 
defined seasonal environment for 50,000 generations.  Over this time, much 
adaptation and specialization to the environment has occurred.  The presence of 
citrate in the growth media selected one lineage to gain the novel ability to utilize 
citrate as a carbon source after 31,000 generations.  Here we test whether other ! 9!
strains have specialized to rely on citrate after 50,000 generations. We show that 
in addition to the citrate-catabolizing strain, three other lineages evolving in 
parallel have acquired a dependence on citrate for optimal growth on glucose. 
None of these strains were stimulated indirectly by the sodium present in 
disodium citrate, nor exhibited even partial utilization of citrate as a carbon 
source. Instead, all three of these citrate-stimulated populations appear to rely on 
it as a chelator of iron.  The strains we examine here have evolved specialization 
to their environment through apparent loss of function.  Our results are most 
consistent with the accumulation of mutations in iron transport genes that were 
obviated by abundant citrate.  The results present another example where a 
subtle decision in the design of an evolution experiment led to unexpected 
evolutionary outcomes. 
Introduction 
Evolutionary adaptation to a new environment leads to changes that improve 
function and increase fitness, but it may also result in the deterioration of 
functions not needed in that selective environment. These declines in function 
that accompany adaptation – tradeoffs – are often considered inevitable costs or 
constraints of adaptation [1]. Tradeoffs can either result from antagonistic 
pleiotropy, when adaptive mutations in the selective environment are deleterious 
elsewhere, or from the accumulation of mutations that are neutral in the selective 
environment. A consequence of these tradeoffs is that they prevent ‘Darwinian 
demons’: single super-genotypes that are optimally fit across a spectrum of ! 10!
environments [2]. Instead, there are usually ‘generalist’ organisms that perform 
adequately in a variety of environments that can coexist with ‘specialist’ 
organisms that occupy smaller niches but with greater effectiveness.  
Critical to the emergence of specialization is the constancy of an environment [3]. 
By occupying the same environment for an extended period of time, the 
advantage of maintaining fitness in alternate environments is not realized. 
Organisms may thus be expected to become increasingly specialized to their 
current, static environment. The most obvious form of specialization is a decline 
in the ability to utilize resources or exist in conditions that were not experienced 
during adaptation. Many such examples have been observed during laboratory 
evolution whereby organisms evolved to narrow or shift their range of preferred 
temperatures [4], carbon sources [5,6], host organisms [7], or even laboratory 
water supply [8]. Alternatively, organisms can lose the ability to grow well in the 
absence of a resource that is currently available. Although we are unaware of an 
experimental demonstration of a novel change to dependence upon a supplied 
resource, this has been dramatically and repeatedly observed for microbes 
infecting hosts. These microbes commonly lose the ability to synthesize a 
substantial number of components essential for growth because these are 
available in the host environment, such as the cytoplasm [9] or mouse gut [10]. 
One of the most prominent examples of prolonged adaptation to a single 
environment is the Lenski Long-Term Evolution Experiment (LTEE) [11]. In this 
experiment, 12 populations of Escherichia coli were founded with either the ! 11!
arabinose-negative strain REL606 (populations A-1 to A-6) or the otherwise 
isogenic arabinose-positive derivative, REL607 (A+1 to A+6). These have evolved 
since 1988 in Davis-Mingioli (DM) minimal media [12] batch cultures containing 
glucose as a growth substrate. Over 50,000 generations, the fitness of the evolved 
strains in the evolutionary environment has increased substantially, and in fact 
continues to do so [13]. In line with the expectation of a generalist-specialist 
tradeoff, evolving strains have also specialized for aspects of their static 
environment. Evolved isolates have lower fitness in some alternative 
environments [4, 5, 14, 15], despite the fact that many individual mutations were 
generally beneficial across environments [16]. 
Perhaps the most surprising adaptive change to have occurred during the LTEE 
was the huge increase in fitness of one population due to evolving the ability to 
metabolize citrate, the “inert” metal chelator present in DM minimal medium. 
Disodium citrate (which we will hereafter refer to as citrate) was included in the 
evolutionary growth media as a historical artifact of the media’s original 
formulation for penicillin enrichment of auxotrophs [12, 17]. The common use of 
citrate in minimal media formulations owes to its ability to serve as a chelator of 
Fe (III). Indeed, no direct addition of iron is made to DM minimal media. Given 
the quite low level of glucose used in the LTEE (25 mg/L = 0.14 mM), 
substantially more citrate was present (1.7 mM) than glucose. A diagnostic trait of 
most E. coli strains is that they can only grow on citrate anaerobically, whereas 
Salmonella, for example, can grow on it aerobically. This inability of the ancestral ! 12!
strain to grow on citrate during the aerobic conditions of the LTEE therefore 
initially rendered this organic acid an unavailable secondary resource. Incredibly, 
after 31,000 generations – and by just one of the 12 replicate populations (A-3) – 
the ability emerged to a utilize citrate as a sole carbon source during aerobic 
growth [18]. Interestingly, this was not even the first time E. coli has acquired the 
ability to aerobically utilize citrate. Cit+ E. coli K12 had previously been observed 
to arise spontaneously [19] or via the high expression of the anaerobic citrate 
transporter on multi-copy plasmids in E. coli B [20].  
Besides the remarkable story of novel aerobic utilization of citrate, it is unclear 
whether any of the LTEE lines may have changed in terms of use of citrate as an 
iron chelator. Bacteria commonly have multiple acquisition systems for various 
metals, particularly iron, which is required for aerobic respiration due to the 
hemes found in cytochromes. The acquisition of iron is particularly challenging 
for microbes because of the low solubility of the Fe (III) species that is available 
at neutral pH in oxygenated environments. Consequently, metals are often 
growth limiting in nature in environments ranging from the open ocean [21], to 
host infections [22]. In the context of infections, iron is sequestered by high-
affinity eukaryotic proteins, and the pathogenesis of many infectious diseases 
relies on the ability of bacteria to strip iron from their host. 
Consistent with the fundamental role that iron plays in microbial growth, and its 
relative scarcity, microbes have developed an arsenal of techniques to procure it. 
In E. coli, transcriptional regulators sensitive to the intracellular concentrations ! 13!
of iron down-regulate iron uptake genes when supplies are adequate. Under 
conditions of iron deprivation, these same regulators simultaneously up-regulate 
iron acquisition systems while down-regulating proteins requiring iron [23, 24]. 
One mechanism to obtain iron is to secrete and reabsorb small molecules called 
siderophores that chelate extracellular Fe (III), as well as the transporters to 
utilize them. E. coli also has the ability to take up Fe (II), and a transport system 
to directly capture Fe (III) from host proteins like transferrin or lactoferrin, or 
from heme [25]. 
 
There is precedent for selection acting upon metal acquisition during 
experimental evolution. Growing Methylobacterium at low levels of cobalt 
repeatedly selected for transposition events upstream of a single cobalt 
transporter, leading to increased uptake rates [26]. Interestingly, the selective 
effect of these mutations was dependent upon both the carbon source and the 
growth rate of cells. Additionally, there have been mutations in metal acquisition 
as a social trait. Genotypes of Pseudomonas aeruginosa that fail to produce 
siderophores have emerged during adaption in laboratory conditions, as well as 
over the course of infection in the lungs of cystic fibrosis patients [27, 28]. 
Because excreted siderophores become public goods, in well-mixed 
environments, non-producing cheaters can have a selective advantage over 
producers [29].  
 ! 14!
Here we investigated whether other strains from generation 50,000 of the Lenski 
LTEE have evolved to become dependent on citrate for their performance 
growing on glucose. There are four non-exclusive hypotheses for the dependence 
of glucose growth of each population upon citrate. H0: The null hypothesis is that 
there is no significant stimulation (or perhaps even inhibition), H1: As disodium 
citrate is the sole source of sodium in the LTEE media, there may be stimulation 
by sodium ions in a manner independent of citrate itself, H2: Evolved strains use 
– at least partially – citrate as a growth substrate (e.g., the Cit+ A-3 population), 
and H3: Evolved strains have come to rely upon citrate to chelate iron present in 
the media.  
 
We found that the ancestors and most of the evolved populations were largely 
insensitive to the presence of citrate (H0). In contrast, however, three lineages in 
addition to the Cit+ A-3 population have evolved increased growth rate and yield 
in the presence of citrate. In no case was this was due to sodium ions (H1). Unlike 
the Cit+ A-3 (H2), however, these lineages neither grew on citrate directly nor 
incorporated isotopic label from citrate during growth on 100% U-13C-glucose. In 
contrast, these three lineages were at least partially rescued by the direct addition 
of Fe (II). These data are consistent with H3: these three populations have 
evolved to rely on citrate for its original intent, as a chelator of iron. As such, 
these three populations have evolved a novel dependence upon citrate due to ! 15!
reduction in citrate-independent glucose growth rather than the gain of growth 
on citrate as a carbon and energy source. 
 
Results 
Evolved strains acquired dependence on citrate 
In order to test for acquired dependence upon citrate (i.e., rule out H0), we 
compared growth rate and yield on glucose either with or without citrate for the 
ancestors and 12 clonal isolates from the 50,000 generation LTEE populations 
(Figure 2.1). Growth rate is known to be strongly correlated with fitness in batch 
cultures in general, and in the LTEE in particular [30]. Yield, while not a 
component of fitness during batch culture, conveys additional information about 
cell physiology and was therefore also analyzed. Differences seen in apparent 
final yield was not explainable by the changed osmolality due to the addition of 
citrate to the media; citrate caused no detectable change in optical density 
(p=0.95, two-tailed paired T test). Both ‘small’ and ‘large’ clones from the A-2 
population were included [31] in the analysis.  ! 16!
Figure 2.1: Dependence of growth on glucose upon the presence of 
citrate for the ancestors and evolved strains. The ratio and error for 
growth parameters was calculated by fitting a log-linear model with the 
strain:media interaction terms and block as the dependent variables. Unlike the 
ancestors (first two values), strains from three of the evolved populations were 
strongly stimulated by citrate in terms of both (A.) growth rate and (B.) yield. The 
remaining nine Cit- lineages, like their ancestors, exhibit little to no dependence 
upon citrate. We tested both ‘large’ (A-2A) and ‘small’ (A-2C) clones from the A-2 
population, as it is known to have a stable, long-term polymorphism. Values 
represent the mean and 95% confidence intervals for the ratio of growth on 
glucose with citrate to growth without citrate for a given strain. ! 17!
The Cit+ A-3 population was seen to grow faster and to a much higher final yield 
in the presence of citrate, as previously reported [18]. The growth rate of the 
ancestor REL606 was neither significantly decreased nor enhanced by the 
addition of citrate (P=0.71, two-tailed Welch’s T test unless stated otherwise), but 
there was a very slight, but significant increase in yield (P=0.0001). This 
difference in yield was not significant for the REL607 ancestor, for which we ran 
fewer replicates.  Nine of the 13 evolved strains had similarly small increases in 
rate or yield. While in some cases there were statistically significant increases, the 
effect was small. For the remaining three strains, however, the increase was much 
greater for both rate and yield. In the presence of citrate, A-2A, A-4 and A+6 all 
experienced significant increases in both rate and yield (Respectively, rate: 
P=1.6x10-7, P=5.3x10-13, and 3.1x10-12, yield 1.6x10-14, 1.7x10-7, and 1.8x10-9).  
Indeed, these effects were quite substantial: the growth rate of A+6 with citrate 
was 3.75 times faster than growth without citrate, and the final yield of A-2A 
increased by 80% by the addition of citrate. In comparison, at the 1mM 
concentration of glucose used, the Cit+ A-3 strain grew 1.2 times faster and 
increased in final yield by 100% with the addition of citrate.  To explore the 
nature of the citrate dependence, we focused on these three strains for which the 
effect was greatest, and omitted strains for which the effect was marginal (as well 
as the Cit+ A-3).  
 
 ! 18!
Disodium citrate dependence is not driven by sodium 
One possible explanation for the effect of citrate could be stimulation by the 
addition of sodium (3.4 mM Na+ cations), as disodium citrate was the only source 
of the cation in the medium (H1). In order to test for this possible effect, we 
compared the stimulatory effect of disodium citrate to citric acid of the same 
concentration (which was pH-normalized with KOH). Both growth rates and 
yields with citric acid for the three citrate-stimulated evolved strains were nearly 
identical to those from disodium citrate (Figure 2.2). The only differences that 
were statistically distinguishable were those for yield for A-2A (P=0.016) and A-4 
(P=0.004), which were in fact slightly higher on citric acid than on disodium 
citrate. This suggests that the growth phenotype we see in these evolved strains is 
related to citrate rather than a side-effect of sodium.  
 
 
 
 
 
 ! 19!
 
Figure 2.2: Dependence of growth on glucose is due to citrate itself 
rather than the coincidental addition of sodium. The ratio and error for 
growth parameters was calculated by fitting a log-linear model with the 
strain:media interaction terms and block as the dependent variables. Both the 
relative (A.) growth rate and (B.) yield on glucose for the three lineages that were 
strongly stimulated by the addition of sodium citrate (black circles) can be 
achieved by simply adding citric acid (white diamonds). Values represent the 
mean and 95% confidence intervals for the ratio of growth of that strain on 
glucose with the supplement to growth without. ! 20!
 
Evolved strains are unable to utilize citrate as a carbon source 
Given that citrate stimulation of glucose growth was not due to sodium, we next 
examined whether or not strains could directly metabolize citrate (H2). First, we 
asked whether any of these three citrate-stimulated strains grow with citrate as a 
sole carbon source. When cultured in DM containing citrate but no glucose, there 
was no measurable increase in OD after 24 hours (A-2A P=0.45, A-4 P=0.40, 
A+6 P=0.72). Thus, unlike the Cit+ A-3 population, none of these isolates appear 
to be capable of growth on citrate alone.  
Although the three citrate-stimulated evolved isolates were found to still be Cit-, 
this result did not rule out possible co-metabolic use during growth on glucose. 
To explore this possibility, we determined whether carbon from the citrate was 
incorporated into biomass during growth on glucose. We grew cells in 100% U-
13C labeled glucose at 1 mM, both with and without unlabeled (i.e., ~99% 12C) 
citrate, and looked for differential incorporation of 13C into the amino acids of the 
growing cells under these two conditions. Using gas chromatography-mass 
spectrometry (GC-MS), we compared the mass distribution vectors for fragments 
of derivatized amino acids from the cultures (Figure 2.3). Since CO2-utilizing 
reactions represent a source of naturally occurring carbon, it is expected to 
observe less than 100% 13C in amino acid fragments. If citrate were co-utilized it 
would enter directly into the citric acid cycle and be incorporated into biomass, ! 21!
which would dilute the incorporation of 13C from glucose into amino acids. We 
compared the peaks corresponding to fully-labeled fragments using a Wilcoxon 
signed-rank test.  For the Cit+ A-3 population, there was a significant difference 
in incorporated label in the presence of unlabeled citrate (P=0.0006), but for the 
other citrate-dependent strains there was no significant difference (A-2A: 
P=0.33, A-4: P=0.73, A+6: P=0.47) (Figure 2.3B-C). These data confirm that 
these three strains are not utilizing citrate as a carbon source to any measurable 
extent. 
 
 ! 22!
 
Figure 2.3: GC-MS technique to determine if citrate was incorporated 
into the amino acids of biomass during glucose growth. Amino acids 
from cells grown on 100% U-13C-glucose with or without citrate were analyzed via 
GC-MS. (A.) A representative GC-MS chromatogram of total ion intensity 
indicating the presence and separation of derivatized amino acids. (B) Mass 
spectra for an example fragment (from glycine) when A+6 was grown on glucose 
with citrate (black) or without (white), and (C) when the citrate-consuming A-3 
was grown with and without citrate. For each amino acid, one or more 
characteristic mass fragments are observed whose mass distribution spectra ! 23!
Figure 2.3, continued: shows the relative amount of fully 13C-labeled fragment 
(peak at 248 for the M-57 fragment of glycine) compared to total of all ions for 
that fragment (sum of peaks 246 to 248). Across all amino acids, there was not 
significant decrease in 13C-labeling from glucose except in the REL-3 line where 
unlabelled citrate was clearly incorporated into biomass.  Error bars represent 
standard deviations of 3 biological replicates. 
Citrate dependence is related to its role as an iron chelator 
Having rejected hypotheses H0-H2 for the three citrate-dependent strains, we 
tested the remaining hypothesis that the effect of citrate is related to its role as a 
chelator in iron acquisition (H3). E. coli can take up ferrous iron with the Feo and 
Efe transporters without the involvement of citrate [25]. We first tested whether 
providing sufficient iron (as ferrous iron to 10 µM) in the absence of citrate would 
enhance growth on glucose of the three citrate-dependent evolved isolates 
(Figure 2.4). For one of the citrate-dependent strains, A-4, the iron greatly 
increased the growth rate and yield to values indistinguishable from that 
achieved via citrate (P=0.06 and P=0.11, respectively). A similar effect was seen 
for A-2A, where iron increased growth rate and yield to ~90% that achieved by 
citrate, a small, but significant difference (P=0.008 and P=5.6x10-5, respectively). 
For the third strain, A+6, the direct addition of iron significantly increased rate 
(P=5.6x10-8) and yield (P=0.0008), but this increase amounted to only ~40% of 
the yield increase and ~13% of the rate increase seen with the addition of citrate.  ! 24!
One possible explanation for the evolved strains’ acquired dependence upon 
citrate would be a defect in either production or uptake of iron chelating 
siderophores. To test whether the citrate-dependent strains had become deficient 
in their ability to secrete siderophores, we grew the three citrate-dependent 
evolved isolates in media without citrate that had been conditioned by the growth 
of the ancestral REL606 and then re-supplemented with glucose. Unlike what has 
been observed previously for siderophore-defective strains [32,33], none of the 
citrate-dependent strains grew faster or to a higher final yield on the spent media 
than on DM without citrate (at an 0.05 level, Welch’s 1-tail T test) (Figure 2.4). 
This argues against defects in siderophore production as the sole cause of citrate 
dependency, but does not rule out the possibility that it is related to the ability to 
transport iron-siderophore complexes.  ! 25!
 
Figure 2.4: Direct addition of iron, but not spent medium, stimulates 
growth on glucose for citrate-dependent evolved lineages. The ratio and 
error for growth parameters was calculated by fitting a log-linear model with the 
strain:media interaction terms and block as the dependent variables. Both the 
relative (A.) growth rate and (B.) yield of the three strains from populations 
stimulated by sodium citrate (black circles) are at least partially enhanced by 
direct addition of 10 µM Fe (II) (as ammonium iron sulfate, red squares). In 
contrast, growth in spent media re-supplemented with glucose (blue triangles) 
did not stimulate growth. Values represent the mean and 95% confidence 
intervals for the ratio of growth of that strain on glucose with the supplement to 
growth without. ! 26!
Discussion 
Here we report that by 50,000 generations, three strains from the 11 LTEE 
populations not previously shown to be dependent on citrate now grow on 
glucose in a manner that is strongly dependent on the presence of citrate. Thus, 
eight of the populations have retained the ancestral phenotype of marginal - if 
any - stimulation by citrate (H0 above) and one has famously become Cit+ and 
can readily grow on it as a sole carbon and energy source (H2). For the remaining 
three populations whose glucose-growth was substantially enhanced by citrate, 
our experiments allowed us to reject both the hypothesis that this stimulation 
was due to a side-effect of adding sodium (H1) as well as that it was due to co-
metabolism during glucose growth (H2). The remaining hypothesis – citrate as 
an iron chelator (H3)– appears to best explain this phenotype, as direct addition 
of iron in the absence of citrate stimulated glucose growth. 
What physiological mechanism may have caused this evolved dependence on 
citrate? The ability of ferrous iron to largely restore the phenotype of rapid 
growth on glucose is the strongest evidence for a loss of function in metal 
acquisition. The primary iron acquisition system for E. coli under aerobic 
conditions is via siderophores [25]. The fact that citrate-dependent strains do not 
benefit from growth on media conditioned by their citrate-independent ancestor, 
however, suggests that their dependence is unlikely to be due to an inability to 
produce or secrete siderophores. The most plausible explanation for their citrate-
dependence would therefore be mutations involved in siderophore uptake. Since ! 27!
strains A-2A and A-4 were almost completely rescued by ferrous iron, they 
appear to have no defects in their systems for direct iron uptake. On the other 
hand, A+6 was only mildly stimulated by ferrous iron, which would suggest this 
strain either has additional mutations in genes related to direct ferrous iron 
transport, defects in global regulators that stimulate up-regulation of iron-
acquisition genes under iron starvation [24], and/or another non-iron-related 
dependency on the presence of citrate. Given the large number of genes involved 
in iron transport (the ferric uptake regulon alone consists of ~30 iron-transport-
related genes [34]), the most useful first step for answering these questions will 
come from analysis of candidate causal mutations from the genome sequences 
from these lineages, which are in progress (personal communication, R.E. Lenski 
& D. Schneider). 
At this point, it is not possible to conclude whether the new citrate dependence 
during growth on glucose is the result of adaptation or the accumulation of 
mutations. Previous experiments in the LTEE have suggested that the 
predominant mechanism for tradeoffs in the evolved strains has been 
antagonistic pleiotropy, and not the accumulation of mutations [5]. However, 
since this initial study, 30,000 more generations have passed, and many more 
mutations have occurred. In the genome sequence published for the A-1 lineage, 
for example, there were only 29 nucleotide substitutions after the first 20,000 
generations, but 598 more accumulated in the subsequent 20,000 generations.  
This striking increase in mutation rate was due to acquiring a mutator phenotype ! 28!
during the latter period [13]. In general, the respective impacts of mutation 
accumulation versus antagonistic pleiotropy should be revisited given the 
increased mutation rate in many of the strains, and the amount of time that has 
passed.  
Though definitive statements cannot be made, mutation accumulation seems like 
a plausible cause of the observed acquisition of citrate dependence. Iron 
transport genes were presumably superfluous in the constant presence of high 
levels of citrate for 50,000 generations. Additionally, the large number of genes 
involved in iron uptake would provide a reasonably large mutational target. 
Finally, all three of the strains that show strong citrate dependence during growth 
on glucose are amongst those that have also acquired a mutator phenotype; 
mutations to uvrD, mutL, and mutS have increased their mutation rates 100-
1000 fold [5, 35]. This result in itself is not statistically significant, as 6 of the 
parallel populations have acquired this phenotype by 50,000 generations, so the 
probability by chance that all three citrate-dependent strains are mutators is 0.1. 
The fact that they are all mutators, however, is consistent with the hypothesis 
that mutation accumulation drove the observed phenotypic changes. As with the 
above speculation about the identity of the mutational targets leading to citrate-
dependency, the selective mechanism leading to their incorporation will require 
identification and introduction into the appropriate backgrounds to test the 
fitness of the dependency-inducing mutations.  
 ! 29!
Conclusions 
We have uncovered a second form of interaction with citrate that occurred during 
the 50,000 generations of the LTEE: three of the 12 Cit- strains we examine now 
require its presence as an iron chelator for maximal growth on glucose. This 
interaction is due to an acquired dependence on citrate to carry out a function 
that populations have lost, which contrasts with the gain of novel function 
observed in the Cit+ A-3 population. Unlike the strong selection for the ability of 
A-3 to catabolize citrate, selection was likely either weak or absent in the loss of 
citrate-independent glucose performance. In this regard, the constant 
environment of the LTEE was perhaps not unlike that encountered along the 
evolutionary path to intracellular symbionts, whereby specialization emerges not 
so much from gain of new traits as from the persistent loss of traits rendered 
unnecessary. 
A final subtext for considering the emergence of citrate-dependence during 
glucose growth is that subtle decisions in the design of evolution experiments can 
have unpredictable impacts. By addressing one complication in experimental 
design, one can unknowingly create new adaptive opportunities. Citrate was 
present in DM media from the start of the experiment despite a quite small, 
marginal difference between growth of the ancestor in its presence or absence. 
This seemingly insignificant detail – combined with tens of thousands of 
generations of adaptation – has led to unexpected phenomena that range from ! 30!
the incredible acquisition of aerobic citrate metabolism, to the dependence on 
citrate as an iron chelator. 
 
Materials and Methods 
Strains and LTEE conditions 
 
Escherichia coli B isolates were obtained from the Lenski LTEE [11] after 50,000 
generations. Briefly, 12 populations of E. coli were founded with either the 
arabinose-negative strain REL606 (populations A-1 to A-6) or the arabinose-
positive derivative, REL607 (A+1 to A+6). These have been evolved since 1988 in 
50 mL flasks containing 10 mL of modified Davis-Mingioli (DM) minimal media 
[36] (which we refer to as DM media) with 139 µM glucose (25 mg/L) as a growth 
substrate. One liter of DM consists of 7 g potassium phosphate (dibasic 
trihydrate), 2 g potassium phosphate (monobasic anhydrous), 1 g ammonium 
sulfate, 0.5 g disodium citrate, 1mL 10% magnesium sulfate, 1mL 0.2% thiamine 
(vitamin B1), and a carbon source- here glucose. These populations have been 
cultured at 37 °C while shaking at 120 rpm, and have been transferred daily via 
1:100 dilutions (~6.64 net doublings per day). 
The isolates analyzed in this experiment consisted of the ancestral lines REL606 
and REL607, as well as the ‘A’ clone frozen at 50,000 generations from 11 of the 
12 populations (A-1A: REL11330, A-2A: REL11333, A-3: REL11364, A-4A: ! 31!
REL11336, A-5A: REL11339, A-6A: REL11389, A+1A: REL11392, A+2A: 
REL11342, A+3A: REL 11345, A+4A: REL11348, A+5A: REL11367, A+6A: 
REL11370). The A-2A clone is from the ‘large’ lineage that has coexisted with a 
cross-feeding ‘small’ lineage for tens of thousands of generations [31].  We 
therefore also examined an A-2C ‘small’ clone (REL11335).  
 
Before growth and GC-MS experiments, acclimation cultures were inoculated 
from freezer stocks and grown for 24 hours in DM 1 mM glucose without citrate.  
 
Growth Rate and Yield Experiments 
To measure growth rate and yield, cultures were grown in 50 mL flasks 
containing 10 mL of DM minimal media (the same media as the evolution 
experiment) with 1 mM glucose.  In order to avoid extremely low optical 
densities, growth assays were conducted at 1 mM, which is higher than the 25 
mg/L = 0.14 mM that was used in the “DM25” medium of the evolution 
experiment. It is, however, closer to the concentration of glucose in the 
evolutionary environment than either the 250mg/L or 1000mg/L that has 
previously been used for physiological assays on these strains [13, 30, 37]. 
DM+citrate media contained disodium citrate at a concentration of 1.7 mM, as 
normal. DM+iron was supplemented with ammonium iron sulfate, mixed fresh 
the day of the experiment, to 10 µM of Fe (II). Ammonium is already present in 
DM (as ammonium sulfate) at a concentration of 7.6mM, so 10 µM addition in ! 32!
iron sulfate does not meaningfully change its concentration. DM+citric acid was 
DM supplemented with 1.7 mM citric acid and pH balanced with KOH.  Spent 
media was produced by growing the ancestral strain REL606 in DM 1 mM 
glucose without citrate for 24 hours, centrifuging to remove the majority of the 
cells, and then filtering with a 0.2 µm filter to sterilize. Citrate was omitted in 
order to ensure that it did not suppress siderophore production.  This spent 
media was supplemented to 1 mM glucose with filter-sterilized 10% glucose 
solution, and compared to DM without citrate identically supplemented with 
glucose.  
For growth rate experiments, OD600 was measured on a BioRad SmartSpec Plus 
(Philadelphia, PA) spectrophotometer every hour until there was a detectable 
increase in OD, then approximately every 30 minutes until stationary phase was 
reached. Yield was measured as OD600 after 24 hours. Growth rate was calculated 
with Growth Curve Fitter, an in-house software package that fits exponential 
curves using points in the log-linear range of observations (N.F. Delaney & CJM, 
unpublished).  To determine growth rates, we subtracted the blank (optical 
density at t=0), and fitted all points after a change in OD was measurable until 
the point before stationary phase was reached (4-6 points).  The exception was 
for the Cit+ A-3 strain, for which the growth rate was fitted for growth on only the 
glucose portion of the diauxic growth curve.  Between 4 biological replicates (for 
citrate-insensitive strains) and 19 (for the ancestor) were run for each condition. 
The statistical difference between growth parameters for different conditions was ! 33!
calculated directly from the data using Welch’s T test.  In order to plot the 
relationship between the data in an intuitive way as a ratio, the ratio and error for 
growth parameters was calculated by fitting a log-linear model with the 
strain:media interaction terms and block as the dependent variables using R (R-
Project software).  
GC-MS analysis of incorporation of carbon from glucose versus citrate 
Incorporation of 13C was measured as previously described [38]. Strains were 
grown with or without citrate in 100 mL of Davis minimal media with 1 mM U-
13C glucose (Cambridge Isotope Laboratories, Andover, MA). At stationary phase, 
all cells were pelleted from the media, hydrolyzed overnight in 6 M HCl, and 
dried. The dry cell material was then derivatized for an hour at 85 °C with 40 µL 
each of dimethylformamide (DMF) and N-tert-butyldimethylsilyl-N-
methyltrifluoroacetamide with 1% tert-butyldimethyl-chlorosilane (TBDMSTFA). 
The derivatized cell material was injected into a Shimadzu QP2010 GC-MS 
(Columbia, MD). The injection source was 230 °C. The oven was held at 160 °C 
for 1 min, ramped to 310 °C at 20 °C min-1, and finally held at 310 °C for 0.5 min. 
The flow rate was 1 mL min-1 and the split was 10. The column was a 30 m Rx1-
1ms (Restek, Bellefonte, PA). Three biological replicates were run for each isolate 
(except A-2A in which one run failed). 
In all samples the percent of each amino acid that was uniformly labeled with 13-C 
molecules was determined using FiatFlux qualitycheck [38]. For each amino acid ! 34!
fragment that was detected in all biological replicates, the difference in average 
percent of uniformly labeled fragment was determined for samples grown with 
and without citrate. Finally we used a non-parametric Wilcoxon signed-rank test 
to determine whether there was a significant difference in labeling between 
treatments. 
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Evolutionary adaptation to a constant environment is often accompanied by 
specialization and a reduction of fitness in other environments. We assayed the 
ability of the Lenski Escherichia coli populations to grow on a range of carbon 
sources after 50,000 generations of adaptation on glucose. Using direct 
measurements of growth rates, we demonstrated that declines in performance 
were much less widespread than suggested by previous results from Biolog assays 
of cellular respiration. Surprisingly, there were many performance increases on a 
variety of substrates. In addition to the now famous example of citrate, we ! 40!
observed several other novel gains of function for organic acids that the ancestral 
strain only marginally utilized. Quantitative growth data also showed that strains 
with higher mutation rate exhibited significantly more declines, suggesting that 
most metabolic erosion was driven by mutation accumulation and not by 
physiological tradeoffs. These reductions in growth by mutator strains were 
ameliorated by growth at lower temperature, consistent with the hypothesis that 
this metabolic erosion is largely caused by destabilizing mutations to the 
associated enzymes. We further hypothesized that reductions in growth rate 
would be greatest for substrates used most differently from glucose, and we used 
flux balance analysis to formulate this question quantitatively. To our surprise, 
we found no significant relationship between decreases in growth and 
dissimilarity to glucose metabolism. Taken as a whole, these data suggest that in 
a single resource environment, specialization does not mainly result as an 
inevitable consequence of adaptive tradeoffs, but rather due to the gradual 
accumulation of disabling mutations in unused portions of the genome. 
 
Introduction 
Evolving populations face the fundamental dilemma that there is no single 
phenotype that is optimal in all environments. When an evolving population 
occupies the same selective environment for an extended period of time, no 
advantage is realized by maintaining fitness on resources it no longer encounters. 
Adaptation to a selective environment can result in correlated responses in ! 41!
alternative environments. While these can be synergistic improvements, a 
response that decreases fitness in other environments is known as specialization. 
This prevents the rise of ‘Darwinian demons’: single super-genotypes that are 
optimized across all conditions [1]. It is critical to understand the origin of 
specialization because it underlies the origin and maintenance of diversity- it is 
why ‘the jack of all trades is a master of none’ [2]. 
Specialization can result from either selective or neutral processes. Antagonistic 
pleiotropy describes when natural selection favors changes that are beneficial in 
the current environment but reduce function in other environments. 
Alternatively, specialization may result from mutations that decrease fitness in 
alternative environments that are neutral in the selective environment. These 
mutations have the potential to either drift or hitchhike to fixation via “mutation 
accumulation”. As neutral mutations accrue in proportion to the mutation rate, 
the clearest evidence of mutation accumulation can come from excess 
specialization in mutator lineages, which contain defects in mutational repair 
that can elevate mutation rates ~100-fold [3]. In contrast, where specialization is 
rapid and occurs in parallel across lineages, a pattern commonly seen for 
adaptation itself, this has been cited as support of selection-driven antagonistic 
pleiotropy [4].  
The experimental evolution of 12 populations of Escherichia coli grown for 
thousands of generations on a single substrate has been used to distinguish 
whether selective or neutral processes drive metabolic specialization [4]. The ! 42!
populations were part of the Lenski Long-Term Evolution Experiment (LTEE) 
[5], in which wild-type E. coli B have been diluted 1:100 daily and re-grown in 
well-mixed medium containing glucose as the sole usable carbon source. After 
20,000 generations (20k), competitive fitness on glucose had increased by ~70%. 
However, respiration assays in static 96-well Biolog plates (Hayward, CA) [6] 
suggested dramatic decreases in metabolic performance on alternative 
substrates. These declines occurred rapidly and in parallel across populations, 
coincident with the largest gains in fitness. This was suggested to indicate 
selection-driven antagonistic pleiotropy as the main mechanism of specialization. 
Furthermore, because there was only a weak, non-significant excess of declines 
by the populations which had become mutators earlier in the experiment [3], this 
suggested neutral mutation accumulation played little role, if any, in glucose 
specialization by 20k. 
In this study we have readdressed the basis of specialization in the LTEE 
populations, motivated by our discovery that the growth rates of isolates in well-
mixed media are poorly captured by assays of cellular respiration in static, 
proprietary media. Given this surprising finding, we analyzed the selected (i.e., 
glucose) and correlated responses of isolates from both 20k and 50,000 
generations (50k) from four perspectives: 
(i) Generality and parallelism of specialization- Is there an overall pattern of 
decreased growth performance on alternative substrates? Is the pace and pattern 
of declines in function consistent with antagonistic pleiotropy? ! 43!
(ii) Novel gains of function- Besides the prior example of evolution to catabolize 
citrate present in the medium [7], are there any other substrates used by evolved 
isolates that are not utilized by the ancestors? 
(iii) Role of elevated mutation rate driving mutation accumulation- Will the 
30,000 generations that have passed since 20k have lead to sufficient mutation 
accumulation for the mutators to exhibit significantly greater decreases in growth 
than non-mutators?  
(iv) Predictability of catabolic declines- Can we predict which substrates would be 
metabolized less effectively based upon the similarity of their use to glucose? Is 
there a pattern to this specialization that might suggest a common biophysical 
basis behind them for the mutator lineages? 
  
Results 
Respiration assays indicated broad declines in function across substrates, 
including those where adaptation occurred 
As a first step to readdressing specialization in the LTEE populations, we sought 
to replicate the Biolog respiration results at 20k presented by Cooper and Lenski 
[4], as well as extend this analysis to the populations at 5ok. Despite changes in 
the Biolog assay itself since the previous study, we recovered a similar pattern for 
the panel of substrates (Supplementary Figure 3.1).  ! 44!
The validity of Biolog assays as a proxy for strain improvement came into 
question after finding decreases for the very substrates on which selection 
occurred. (Figure 3.1A). Despite abundant evidence of improvement from 
competitive fitness assays [4] and growth rates [8], respiration on glucose 
consistently decreased over the course of the experiment. Furthermore, although 
one lineage in the A-3 population evolved to utilize as a carbon source the citrate 
included in Davis Minimal (DM) medium [7], it produced a statistically 
indistinguishable respiration value from the other Cit- isolates at 50k 
(Supplementary Figure 3.2).  
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Figure'3.1:!Biolog'measurements'are'a'poor'proxy'for'growth'performance.'A)'
Biolog!AUC!as!measured!for!the!D=glucose!on!Biolog!plates.!The!evolved!strains!have!
a!lower!AUC!value!than!the!ancestor!on!glucose,!the!carbon!source!available!during!
evolution!(P<0.0001,!Welch’s!two!sample!T=test).!The!mean!AUC!for!the!20k!and!
50k!isolates!on!glucose!are!not!statistically!different.!B)!Scatter!plot!showing!the!
measurement!of!function!as!Biolog!AUC!vs.!growth!rate!on!all!substrates,!for!all!
strains!at!20k!and!50k!generations!as!well!as!the!ancestors.!The!regression!shown!is!
for!substrates!after!removal!of!categorical!disagreements!(growth!without!
respiration!or!respiration!without!growth,!167/702!in!total).!
!
!
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Growth rates reveal a balance of decreased and increased performance across 
substrates  
Given that the selective substrates with known fitness improvement had 
decreased cellular respiration, we turned to direct measurements of growth rates 
across a wide panel of substrates using a robotic growth analysis system [9,10]. 
By measuring growth rate we capture the demographic metric best-correlated 
with competitive fitness in the evolutionary environment [11]. As the LTEE was 
performed in shaken, fully-aerated flasks, these well-mixed 48-well plates were a 
closer match to the evolutionary environment than unshaken 96-well plates, as 
unshaken plates commonly exhibit sub-exponential growth due to oxygen 
limitation [10]. While Biolog uses a proprietary minimal media, for the growth 
rate measurements we used the same Davis Minimal (DM) media as the LTEE 
experiment. We omitted citrate, however, as this choice allowed us to include the 
Cit+ A-3 population in our analysis. We chose carbon sources based upon the 
substrates for which significant, parallel decreases were previously observed via 
respiration assays [4], as well as citrate and several sugars on which growth 
tradeoffs were previously measured after 2,000 generations [12]. 
Comparing growth rates to respiration data, it becomes evident that the latter is 
not an accurate assay for growth (Figure 3.1B). There were many cases where 
respiration occurred without growth, as 156 out of the 702 strain/substrate 
combinations measured did not permit growth but did have measurable 
respiration- a known feature of Biolog assays [6]. Even after removing these ! 47!
categorical disagreements, and a smaller number of instances of growth without 
respiration (11 strain/substrate combinations), Biolog respiration values were a 
poor predictor of growth rate (R2=0.18, linear regression F-test(1,499)=108.8). 
Growth rate data across substrates revealed a surprising degree of correlated 
gains in performance (Figure 3.2). Indeed, at 20k, there were actually more 
correlated increases in rate than decreases (165 vs. 99, respectively, P<0.0001 for 
binomial two-sided test with null of random gains and losses). By 50k, the picture 
had reversed, now with more decreases than increases (167 vs. 119, P=0.005, 
binomial two-sided test).  
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Figure'3.2:!Relative'growth'rates'across'a'variety'of'growth'substrates'for'
evolved'strains'from'20k'(A)'or'50k'generations'(B).!Heatmaps!indicate!the!log!
ratio!of!growth!rates!relative!to!the!average!of!the!two!ancestors!on!that!carbon!
source.!White!indicates!a!growth!rate!equal!to!that!of!the!ancestor!average,!red!
faster,!and!blue!slower.!The!growth!rates!are!plotted!on!a!log!scale!with!the!limits!of!
the!color!range!set!for!twice!as!fast!and!half!as!fast!as!the!ancestor!average.!An!‘x’!in!
a!box!indicates!that!no!growth!was!observed!for!that!combination!of!strain!and!
substrate!over!48!hours.!Strains!that!were!mutators!by!that!timepoint!are!indicated.!!
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Gains of function on alternate carbon sources 
In addition to many quantitative improvements of growth rates, there were 
several examples where isolates acquired the ability to grow on substrates that 
the ancestral strain could not utilize over the 48 hour time-course of the growth 
experiments. Only one such example was previously known: the aforementioned 
gain of citrate utilization by the A-3 population [7]. We found that this strain also 
gained the ability to grow within 48 hours on three C4-dicarboxylate tricarboxylic 
acid cycle intermediates (succinate, aspartate, and malate). Three other 50k 
isolates from different replicate populations gained the ability to use this same set 
of three C4 dicarboxylate intermediates, as well as fumarate.  
Mutator strains suffered greater declines in growth on alternative substrates  
We compared mutators to non-mutators to ask whether mutation accumulation 
contributed to the observed decreases in growth (Figure 3.2). At 20k generations, 
despite increasing in growth rate more than decreasing (47 vs. 41 cases), the 
mutators were marginally worse, on average, than non-mutators (P=0.03, 
Pearson’s chi-squared test comparing proportion of growth rate reductions). By 
50k there was a stark pattern of mutators declining in catabolic ability compared 
to non-mutators (P<<0.0001, Pearson’s chi-squared test). This can be seen in the 
large block of blue (decreases in rate) for five of the mutators. Non-mutators at 
50k still increased in growth rate more often than they decreased (80 vs. 52 
cases, P=0.018 binomial two-sided test). Because some strains are known to be ! 50!
affected by the absence of citrate even though they cannot use it as a carbon 
source [13], we also tested the growth rate of the 50k strains on alternative 
substrates supplemented with 1.7 mM sodium citrate, as in LTEE growth media. 
Although the reductions in growth rate relative to the ancestor were ameliorated 
in some cases by the addition of citrate, the mutator strains still suffered 
significantly more growth rate decreases than the non-mutators (P=0.003, 
Pearson’s chi-squared test). 
Parallelism of metabolic decreases  
Given the trend of both increased and decreased growth rate on alternative 
carbon sources, we assessed the degree of parallelism with which metabolic 
erosion occurred. We segmented the data by substrate and asked how many 
evolved strains decreased in growth rate or cellular respiration on each substrate. 
We took as a null expectation that decreases in metabolic function are equally as 
likely as increases, and plotted the observed pattern against this null distribution 
(Supplementary Figure 3.3).  
In no case do our observations of metabolic decreases closely match the null 
distribution. As previously, cellular respiration was reduced for nearly all strains 
on all substrates. The observed average number of strains with reduced 
respiration on a substrate was 11.3 at 20k and 12.8 at 50k, 5.3 out of 12 and 6.3 
out of 13 more strains than would be expected given the null distribution 
(P<<0.0001, binomial two-tailed exact test). For growth rate, at 20k on average ! 51!
5.3 strains reduced in growth rate on each substrate, in fact 0.7 fewer strains than 
expected given the null distribution (P=0.01). However, this average somewhat 
masks the bimodal pattern seen in the distribution, with some substrates 
showing nearly no strains reducing growth rate and others nearly all. At 50k, an 
average of 8.3 strains lost function on each substrate, 1.8 more than expected 
(P<<0.0001). Clearly there is some parallelism in decreases in growth rate, but it 
is worth emphasizing that the substrates used in this study were those for which 
widespread, parallel losses in cellular respiration were previously observed.  
Metabolic similarity between substrates was a poor predictor of correlated 
evolved responses 
We asked whether the correlated changes in performance on alternative 
substrates could be predicted based on the similarity of the catabolic network for 
growth on that compound compared to that for glucose. There are two rationales 
that would support this hypothesis. First, there are more loss-of-function 
mutations available for a non-glucose substrate if it uses many unique enzymes, 
and we might expect to see metabolic specialization scale with mutational target 
size under mutation accumulation. These mutations may either simply be 
unguarded by purifying selection, or perhaps even selectively advantageous to 
lose. Second, the balance and direction of flux through various pathways will lead 
to a different optimal allocation of enzymes to balance the needs of catalysis 
versus expression costs. As such, antagonistic and synergistic pleiotropy suggest 
that highly overlapping metabolic flux patterns might be expected to suffer fewer ! 52!
declines, or possibly even synergistic gains, relative to a very differently used 
substrate. A rough approximation of the similarity between different substrates is 
to simply group them as sugars or ‘non-sugars’ that require gluconeogenesis for 
anabolism. To frame this more quantitatively, however, we also used genome-
scale metabolic models to make predictions about specialization.  
In order to approximate internal metabolic states we used Flux Balance Analysis 
(FBA) to generate predicted flux patterns for each compound [14]. This approach 
generates a vector of internal flux values that describes the relative flow through 
every reaction in a cell were it to optimize biomass production per substrate 
molecule. Although selection in batch culture largely acts upon rate, biomass 
production per unit substrate has been shown to effectively capture the growth of 
the LTEE ancestor on glucose, and 50k evolved strains deviated only slightly 
from this pattern [15]. We therefore compared FBA-derived flux vectors using a 
number of metrics to determine their degree of dissimilarity to the flux vector for 
glucose (see Materials and Methods).  ! 53!
 
Figure'3.3:!Substrate'dissimilarity'does'not'predict'metabolic'erosion.!A)'A!
simple!categorization!of!substrates!as!sugars!and!non=sugars!finds!that!the!
correlation!between!relatedness!to!glucose!and!evolved!metabolic!changes!is!the!
opposite!from!what!is!hypothesized.'B)!The!FBA=predicted!mutational!target!size!
does!not!correlate!with!decreases!in!growth!rate.!C)!Hamming!distance!between!
FBA=generated!flux!vectors!for!carbon!sources!partially!predicts!ancestral!growth!
rate.!Black!dots!indicate!the!growth!rate!of!the!2!ancestral!strains.!!268!reactions!
were!predicted!as!necessary!for!optimal!metabolism!on!glucose.!!D)!Hamming!
distance!between!a!substrate!and!glucose!does!not!correlate!with!increases!or!
decreases!in!growth!rate.!The!y!axis!is!the!log!of!the!ratio!of!growth!rate!relative!to!!! 54!
Figure'3.3,'continued:'the!ancestor,!with!all!ratios!greater!or!less!than!e2!binned!at!
the!axis!limit.!For'C=D,!purple!dots!are!mutator!strains,!orange!dots!are!non=
mutators.!Larger!dots!at!the!axis!extrema!indicate!more!overlapping!points,!and!the!
shading!between!purple!and!orange!indicates!the!different!proportions!of!mutators!
and!non=mutators!at!that!limit.'For!B=D,!substrates!with!the!same!x!axis!values!were!
plotted!with!a!slight!offset,!and!the!true!value!is!listed!in!the!axis!label.!!!
We first tested whether evolved decreases in growth rate scaled with mutational 
target size. There is no expected behavior under this hypothesis for increases in 
growth rate, so we limited our analysis to combinations of strains and substrates 
for which growth rate had decreased. By identifying the reactions necessary for 
optimal growth on alternative substrates that are not necessary for growth on 
glucose, and determining the number of coding nucleotides necessary for those 
reactions, we were able to approximate the number of available mutations that 
would decrease growth rate on a substrate. Contrary to our hypothesis, we found 
no significant relationship between mutational target size and reduction in 
growth rate (P=0.15, linear regression F-test(1, 146)=2.1) (Figure 3.3B).  
Our hypothesis also suggests that substrates used more similarly to glucose 
would permit more rapid growth. Starting with the simple categorization of 
substrates as sugars and non-sugars, we found no correlation between these 
groupings and changes in growth rate (Figure 3.3A). Indeed, there were many 
reductions in growth rate for sugars other than glucose. To frame this hypothesis 
in a more quantitative way, we compared the Hamming distance between the ! 55!
vector of predicted fluxes for an alternative compound and that of glucose. 
Contrary to our hypothesis, we found no significant relationship between 
metabolic similarity to glucose and correlated responses (P=0.26, linear 
regression F-test(1, 323)=1.27), and any relationship measured was in fact in the 
opposite direction as predicted (Figure 3.3D). As a confirmation that Hamming 
distance between flux vectors for alternative substrates is biologically relevant, 
we found that it was a significant predictor of some of the variance in the relative 
growth rate of the ancestor (P=0.0001, R2=0.26, linear regression F-test(1, 
48)=17.2) (Figure 3.3C). Alternative metrics to Hamming distance performed 
similarly poorly in predicting patterns of tradeoffs (Supplementary Table 3.4). 
These data suggest that the similarity of overall flux patterns is a surprisingly 
poor predictor about which substrates would experience correlated increases or 
decreases in performance.  
Growth for mutator strain was more sensitive to temperature than for non-
mutators 
Linking the mutator-driven metabolic specialization to their vastly elevated 
mutation rate itself, we hypothesized that their abundance of amino acid 
substitutions may generate trends indicative of the types of effects they had upon 
their gene products. The mutator lineages acquired mutations with a rate up to 
0.06 per generation [16]. For the A-1 lineage, by 40,000 generations there were 
627 SNPs, 599 of which were in coding regions, and 513 of those were non-
synonymous [17]. This is a tremendous load of amino acid substitutions, which ! 56!
are viewed as likely to be deleterious due to destabilizing proteins [18-20]. We 
therefore hypothesized that, if protein destabilization was a dominant factor 
affecting growth at 37 °C, we could predictably ameliorate these defects by 
lowering the growth temperature. Non-mutators will have a small number of 
such mutations, but the ~100-fold greater rate of such mutations in the mutator 
genomes should make growth more temperature sensitive than for non-mutators.  
 
Figure'3.4:'Temperature'dependence'of'growth'rate'on'alternative'substrates.!
For!all!strain/substrate!measurements,!we!determined!the!relative!change!in!
growth!rate!by!changing!temperature!from!37!°C!to!30!°C.!For!A=B,!Purple!dots!are!
mutator!strains;!orange!dots!non=mutators.!Points!that!fall!outside!of!the!plot!range!
are!plotted!at!the!edge!of!the!graph.!A)!Effect!of!temperature!change!on!20k!isolates!
B)!Effect!on!50k!isolates.!C)'For!50k!isolates,!the!number!of!mutators!and!non=
mutators!that!were!rescued!from!no!growth!at!37!°C!to!growth!at!30!°C.!
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Growth rate data supports the hypothesis that mutators have general 
temperature-sensitivity. For 50k isolates, growth rate relative to the ancestor at 
30 °C was higher than at 37 °C in 98 cases, compared to only 37 cases where it 
was reduced relative to the ancestor (P<<0.0001, binomial two-tailed exact test) 
(Figure 3.4B). That is, despite the fact that these strains have adapted for 50,000 
generations at 37 °C, the ratio of their growth rate to that of the ancestor is higher 
at the foreign 30 °C than their native temperature. This general improvement at 
the lower temperature was not present for non-mutators (56 improved relative to 
the ancestor by moving to 30 °C, 57 worse- P=0.99, binomial two-tailed exact 
test), and the difference between mutators and non-mutators was significant 
(P=0.0002, Pearson’s chi-squared test). Furthermore, in the cases where evolved 
50k isolates completely lost the ability to grow on substrates, when grown at 30 
°C these losses were ameliorated more than half the time for mutators (35 of 61), 
significantly more than for non-mutators (6 out of 23, P=0.01, Pearson’s chi-
squared test) (Figure 3.4C). 
An alternative hypothesis for the elevated temperature sensitivity of mutators is 
that the phenotype is directly caused by the mutation in mismatch repair rather 
than the accumulation of destabilizing mutations that it caused. For the 20k 
isolates, in most cases growth was better relative to the ancestor at the native 37 
°C than at 30 °C (119 vs. 75, P=0.002, binomial two-tailed exact test) (Figure 
3.4A). There was no significant difference at 20k between this pattern for 
mutators and non-mutators (P=0.20, Pearson’s chi-squared test), and no ! 58!
significant difference in the number of rescues from complete loss of growth 
(P=0.31, Pearson’s chi-squared test), ruling out that mutator status itself 
generates temperature sensitivity. 
Discussion 
Replicate experimentally-evolved populations such as the Lenski LTEE are ideal 
for studying the processes leading to specialization. Here we directly measured 
growth rates in well-mixed conditions rather than cellular respiration in static 
media. This seemingly minor choice generated qualitatively different results, 
leading to the opposite conclusions from those previously made about the 
mechanisms and patterns of specialization during tens of thousands of 
generations of growth on a single substrate.  
The earlier report [4] of widespread, parallel tradeoffs after extended growth on a 
single compound fit comfortably with the general notion that unused capacities 
will tend to degrade after an extended period of disuse. However, the suitability 
of cellular respiration assays for growth performance was seriously challenged by 
our data. There were many cases of ‘false positives’, with respiration on 
substrates that do not support growth, and a weak predictive ability for growth 
even after removing these. The parallel decreases in function observed across 
compounds in the respiration assay seem to be due to cultures becoming worse at 
reducing the dye in the Biolog assay environment. This generic effect was strong ! 59!
enough to mask both adaptation on glucose and the novel gain of citrate use in 
the A-3 50k isolate. 
Little parallelism in metabolic erosion 
Growth rates indicated little evidence in support of widespread antagonistic 
pleiotropy, with more increases than decreases in growth on alternative 
compounds through 20k, and very few parallel declines. There were individual 
counter examples observed, such as the previously characterized universal loss of 
ribose utilization early in adaptation [21], and the tendency for reduced or loss of 
growth on maltose [22-24]. As such, it is clear that examples of antagonistic 
pleiotropy do exist in the data. However, relatively few other substrates showed 
this pattern at 20k or 50k, despite the fact that these substrates were those where 
parallel reductions in respiration were observed. Because selection drives 
antagonistic pleiotropy, it is commonly expected that the early period of rapid 
adaptation would coincide with the most tradeoffs in alternative environments, 
and that the frequent parallelism in the targets of amongst early beneficial 
mutations would drive parallel losses [4]. Given these criteria, the growth data do 
not support antagonistic pleiotropy as the primary driver of specialization. 
There are three implicit assumptions about antagonistic pleiotropy, however, that 
if not met alter the expectations for specialization driven by selection. First, if 
different beneficial mutations occur across lineages, they will not necessarily lead 
to the same pleiotropic tradeoffs. As of 20k, out of the 14 genes screened in all of ! 60!
the populations there were three genes with mutations in all populations and two 
more in a majority. The other screened genes had mutations in a minority or 
none of the other populations, suggesting that a variety of different beneficial 
mutations occurred across lineages [17]. Second, beneficial mutations in the same 
target may have differing pleiotropic effects in different lineages due to other 
mutations present. This “epistatic pleiotropy” [25] has been found to be common 
in multiple model systems [26-29]. Third, the early large-effect beneficial 
mutations may or may not be responsible for greater pleiotropic effects than 
later, smaller effect mutations. Yeast morphological pleiotropy scaled with 
fitness, for example, but the correlation explained only 17% of the variation [30]. 
The first and second scenarios above – distinct mutations or epistatic pleiotropy 
– would lead to a scenario whereby parallel metabolic declines are no longer 
necessarily expected from antagonistic pleiotropy. The third scenario – 
pleiotropy not scaling with selective effect – would mean the temporal dynamics 
of fitness gain in the selective conditions and the rate of performance losses in 
alternative environments need not be tied.  
These caveats underscore our limited ability make conclusions about the role of 
antagonistic pleiotropy in the observed metabolic declines. The only sure 
determinant of whether a correlated change is the result of pleiotropy or neutral 
mutation is to genetically manipulate the strains to isolate the effect of individual 
mutations. This suggests future experiments, for example testing early and 
parallel mutations previously screened for epistatic effects [31] for pleiotropy. ! 61!
Ultimately, as we discuss below, the key determinant of the role of mutation 
accumulation is whether metabolic specialization was substantially affected by 
mutation rate. 
Increases in growth rate on carbon sources other than glucose 
Rather than a general pattern of metabolic specialization, these data revealed an 
unexpected extent of correlated improvements in growth on alternative 
compounds. Why would E. coli maintain or improve performance on substrates 
that had not been supplied for decades? There are three general classes of 
explanations, two of which mirror the processes considered for pleiotropic 
tradeoffs.  
The first explanation for the correlated improvements, and undoubtedly the least 
likely, would be neutral performance gains through mutations that had no 
selective consequence in glucose: the beneficial analog of mutation accumulation. 
If this were the case, mutators might have more increases in rate than non-
mutators, and more improvements would have occurred by 50k than 20k, which 
is the opposite of what was observed.  
The second explanation of the correlated improvements is that the same 
mutations that were beneficial during growth on glucose may have led to gains in 
alternative environments, i.e. “synergistic pleiotropy”. There are known examples 
of this occurring for early mutations in E. coli evolving in these conditions 
[12,32], and it is a common pattern seen across organisms (for example [33]). ! 62!
These synergistic mutations may be generally beneficial in the laboratory 
environment of the LTEE and thus unrelated to carbon source metabolism. 
Indeed, there are examples of both adaptation to generic aspects of a selective 
environment, such as the trace metal formulation [34], and removal or down-
regulation of costly genes or genome regions [21,35,36]. Synergistic pleiotropy 
could also result from mutations that directly improved glucose metabolism, such 
as mutations in the phosphotransferase-mediated uptake system that also 
increased growth on the other sugars imported by this system [12]. 
A third hypothesis for correlated gains of function on alternative compounds is 
that there were additional compounds besides glucose (and citrate) available 
from cell excretions or lysis. The serial transfer regime of the LTEE creates a 
scenario whereby populations use all of their glucose resources within the first 
few hours, and remain in stationary phase the remainder of the day. The 
ancestral E. coli excrete a small amount of acetate in this environment, and this 
increased on average two-fold by 50k generations [15]. It is thus unsurprising 
that the strongest, most universal gain in alternative compounds by 20k was on 
acetate (Figure 3.2A). In terms of cell lysis, this has allowed one population (A-2) 
to maintain a long-term polymorphism for over 40,000 generations. A “large” 
colony lineage that grows fast on glucose but lyses substantially in stationary 
phase cross-feeds a “small” colony lineage that is not as fast on glucose as the 
larges but has specialized as a “cannibal” [37-39]. This results in a stable, 
negative frequency-dependent fitness effect between these strategies. Although ! 63!
an earlier study of the other populations at 20k failed to reject that fitness 
interactions were transitive through time [40], these competitions were 
performed at a 50:50 ratio and thus may have missed interactions that occur 
when one partner is rare.  
Novel gains-of-function 
The most remarkable correlated increases were the several examples of “novel” 
gains of function by evolved isolates on substrates where the ancestor failed to 
grow. The citrate example has been reported previously [7], but we did not expect 
to find other such substrates. These novel gains of function are distinct from what 
was seen for citrate, as over a longer duration (>100 hours) the ancestral E. coli 
seem to grow to measurable density on these substrates. We are currently 
exploring whether these long lags represent slow physiological acclimation or the 
emergence of evolved genomic changes. In the case of the Cit+ A-3 lineage, 
succinate is likely excreted during citrate import [41], thus selection for its use is 
perhaps unsurprising. The fact that several other strains experienced similar 
gains across the same range of C4 dicarboxylic acids, and that this included the 
cross-feeding “small” phenotype clone from the A-2 population appears to 
suggest that these compounds may be excreted, or present during stationary 
phase from lysed cells. 
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Predictability of correlated responses on alternative carbon sources 
With the availability of whole-genome scale metabolic models for E. coli, we 
asked whether we could predict the trend of correlated responses by comparing 
their pattern of use to that of glucose. We proposed a generic, seemingly obvious 
hypothesis that the more different the metabolism of an alternative substrate was 
from the metabolism of glucose, the more likely it would be that populations 
would have decreased (or lost) their ability to use it. As described, this logic holds 
regardless of whether or not selection drove metabolic specialization. In order to 
quantify the similarity of substrates, we applied FBA to compare the predicted 
optimal metabolic flux states for each compound. The data, however, did not 
support our hypothesis: there was almost no relationship between similarity to 
glucose and correlated response. Recent in silico attempts to predict growth 
capability on substrates based on metabolic similarities have had some success 
[42], suggesting that evolution may be acting here on functions not included in 
the model. For example, mutations may have occurred in functions related to 
differential regulation that distinguish these sugars, rather than central metabolic 
enzymes for which their use is nearly identical.  These mutations are known to 
have occurred in the LTEE, for example in spoT and nadR [35,43]. These 
predictions are also based on the assumption that glucose is the only available 
carbon source. If growth on other carbon sources is under selection due to their 
excretion or presence after cell lysis, it may explain some of the lack of predictive 
power here.  ! 65!
Temperature sensitivity of mutators consistent with protein destabilizing 
mutations 
Although the identity of the substrates that experienced tradeoffs (or 
improvements) were not those we expected, we reasoned that the biophysical 
effects of the deluge of mutations in mutators might lead to a predictable pattern 
of temperature sensitivity in these strains. The genomic sequences and data 
available to date [16,17] suggest mutators will have on the order of 500-2000 
non-synonymous mutations, perhaps more. Random amino acid substitutions 
have been shown to be mildly deleterious in general due to destabilizing proteins 
[20]. To ask whether tradeoffs observed in the mutators were at least partly due 
to destabilizing mutations in proteins needed for alternative substrates, we tested 
whether mutators would be more sensitive to changes in incubation temperature 
than non-mutators. Consistent with this hypothesis, we found that the 50k 
mutators performed better relative to the ancestor at 30 °C than at the 37 °C 
temperature where they have evolved. One alternative hypothesis that was ruled 
out is that the mutator allele itself leads to temperature sensitivity, as the 20k 
mutators performed better at 37 °C than at 30 °C, and the changes with 
temperature were not distinguishable from non-mutators. Although other 
alternative hypotheses may explain some of the temperature sensitivity, these 
data are consistent with the hypothesis that neutral degradation of protein-
coding sequences in these strains proceeded via partial destabilization on the way 
to eventual loss of function.  ! 66!
Role of elevated mutation rate driving metabolic specialization 
The comparison of mutators and non-mutators at 50k strongly suggests that 
neutral mutation accumulation was the primary driver of metabolic 
specialization. The difference in metabolic erosion allows us to distinguish the 
overall trend from forms of antagonistic pleiotropy that could have lacked 
parallelism (different mutations or epistatic pleiotropy) or that may have arisen 
late relative to fitness gains (if pleiotropy did not scale with selective effects). 
Despite a significant difference from non-mutators in the proportion of growth 
rate reductions, after 20,000 generations and a decade of adaptation the 
mutators still increased growth rate in more cases than they decreased, and only 
by 50k did mutators as a group have more decreases than increases. By the later 
timepoint five of the seven mutators had decreased growth (or complete loss) for 
essentially every single alternative compound (except citrate and C4 dicarboxylic 
acids for A-3, which were under selection for this strain). Interestingly, the other 
two (A-1, A-2S) do not show this pattern. These counterexamples may be due to 
the fact that A-1 acquired its mutator status late [17], and A-2S is the cross-
feeding generalist described above that adapted to grow upon lysed cell material 
[38].  
The late appearance of metabolic erosion argues for the unparalleled utility of 
truly long-term experiments. A neutral process such as mutation accumulation 
needs time to become apparent, although hitchhiking with beneficial mutations 
can speed their fixation (i.e., “draft” [44,45]). With a reduced effective population ! 67!
size, the window of selective effects that behave neutrally grows. As such, the 
effects of elevated mutation rates and mutation accumulation becomes apparent 
much more quickly with evolution regimes with small bottlenecks, such as single 
colonies [46,47]. The late appearance of specialization also contrasts sharply with 
abundant evidence that lineages can diversify and specialize in mere tens or 
hundreds of generations. In addition to population size, this difference in 
timescale appears to correlate with the type of selective environment, and thus 
the evolutionary process that was responsible. Whereas the Lenski LTEE is 
notable as an environment with a single nutrient resource at high concentration, 
the cases of rapid diversification have involved spatial heterogeneity [48], rate-
limiting resources in a chemostat [49], or the presence of multiple substrates 
simultaneously [50]. In those scenarios, selection is actively pulling on different 
performance features of an organism and antagonistic pleiotropy appears to 
dominate. The relatively slow degradation of catabolic capacity in the LTEE 
suggests that E. coli faces comparatively little tension between improving upon 
glucose and maintaining performance on other substrates, even those which are 
predicted to be utilized in a very distinct manner. Specialization in this case 
appears not to have been a requisite tradeoff of adaptation, but rather a result of 
the degradation of unneeded proteins. 
The fate of mutator strains in the long-term 
Given the severity of metabolic erosion for mutators even in large laboratory 
populations, it is remarkable just how common mutator lineages are in nature. ! 68!
Mutators have been isolated at frequencies over 1%, and seem to be particularly 
common in organisms such as pathogens [51]. The frequency of mutators in 
nature, despite the associated costs, may be partially explained by increased 
evolvability, shown in laboratory medium [52] and in mice [53].  
Our results add substantially to the idea that an elevated mutation rate is an ill-
fated long-term strategy even for large populations, as declines in performance in 
alternative environments will eliminate previously-occupied parts of the niche 
space. Recent findings have suggested that mutators may tend to attenuate their 
increased mutation rate over time [16,54,55], perhaps to avoid the harmful effects 
of Muller’s Ratchet. Thus both tradeoffs in alternative environments and 
mutation load in selective environments may contribute to the paradox that over 
the short-term lineages often benefit from elevated mutation rates, but the long-
term trend across phylogenies has been for stability in mutation rates of free-
living microbes [56]. 
 
Materials and Methods 
Strains and LTEE conditions 
Escherichia coli B isolates were obtained from the Lenski LTEE [5] after 20,000 
and 50,000 generations. Briefly, in the evolution experiment 12 populations of E. 
coli B were founded with either the arabinose-negative strain REL606 
(populations A-1 to A-6) or the otherwise isogenic arabinose-positive derivative, ! 69!
REL607 (A+1 to A+6). These have been evolved since 1988 in 50 mL flasks 
containing 10 mL of Davis minimal media (DM) with 139 µM glucose (25 mg/L) 
as a carbon source. The cultures were grown at 37°C while shaking at 120 RPM, 
and were transferred daily via 1:100 dilutions (~6.64 net doublings per day). 
The isolates analyzed in this experiment consisted of the ancestral lines REL606 
and REL607, as well as the ‘A’ clone frozen at 50k and 20k generations for the 12 
populations. The A-2A clones at 20k and 50k were from the ‘large’ lineage that 
has coexisted with a cross-feeding ‘small’ lineage for tens of thousands of 
generations [57], and thus here we refer to them as A-2L. At 50k we also 
examined A-2C (REL11335), a ‘small’ clone that we refer to here as A-2S. All 
evolved strains are listed in Supplementary Table 3.1. 
Growth Rate Experiments 
For growth rate measurements, we acclimated out of the freezer by inoculating 10 
µL frozen cultures into 630 µL modified DM250 media in 48-well micotiter plates 
(Costar) and growing overnight on a plate shaking tower (Caliper). All growth 
rates were measured at the LTEE selective temperature (37 °C) unless otherwise 
described. The modified DM media is the same as previously used throughout the 
evolution of these strains [5], except it contained 250 mg/L glucose and no 
sodium citrate. Following acclimation, saturated cultures were transferred into 
new plates with a 1:64 dilution in DM media supplemented with 5 mM of a single 
carbon source. Under these conditions, growth in plates correlates well with ! 70!
growth in flasks, both with and without citrate (P<0.0001, R2=0.74, linear 
regression F-test(1,28)=79.3). The!substrates!analyzed!were!those!where!
consistent!reduction!in!cellular!respiration!were!previously!observed,!as!well!as!
several!sugars!for!which!fitness!changes!had!been!previously!measured!after!2,000!
generations [12] and citrate.!Between 3 and 11 biological replicates were run for 
each strain/carbon source combination. 
Optical densities were obtained every 30 minutes to 1 hour on a Wallac Victor 2 
plate reader (Perkin-Elmer), until 48 hours had passed or cultures reached 
saturation, using a previously described automated measurement system [9,10]. 
Growth rates were determined by fitting an exponential growth model using 
custom analysis software, Curve Fitter (N. F. Delaney, CJM, unpublished; 
http://www.evolvedmicrobe. com/Software.html). Representative growth curves 
and fitted growth rates are shown in Supplementary Figure 3.4. The growth rate 
for all strains relative to the ancestor was calculated for each plate (averaging 
over the 2 ancestors, REL606 and REL607), and averaged across plates. Mean 
growth rates relative to the average of the ancestors were used throughout. When 
quantifying the number of increases and decreases in rate for evolved strains, we 
used all of the data for the substrates!for!which!the!ancestor!exhibited!growth=!a!
necessary!criteria!for!the!evolved!strains!to!demonstrate!reductions.!!
!
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Cellular Respiration Assays 
Biolog assays for respiration capacity were run as in Cooper and Lenski [4]. 
Briefly, cultures were grown from freezer stocks for 2 cycles of 1:100 dilution and 
24 hours of growth in 10 mL LB in flasks shaking at 37 °C. LB was used to avoid 
catabolite repression due to growth in minimal media, which could result in 
fewer positive results on non-glucose carbon sources. These cultures were 
inoculated 1:100 into fresh LB and grown for 6 hours before being spun down at 
12,000 g for 10 minutes and rinsed in saline to remove residual medium. Rinsed 
cells were resuspended in IF-0 buffer with dye added (Biolog) to a constant 
density of 85% transmittance, and all wells of Biolog PM1 plates were inoculated 
with 100 µL of this suspension. The plates were incubated, unshaken, at 37 °C. 
OD600 was measured at 0, 4, 12, 24, and 48 hours, and all well readings were 
adjusted by subtracting the reading of the well at 0 hours. A trapezoidal area 
approximation [4] combined the five measurements for each well into one value, 
which reflects the area under the curve (AUC) of optical density versus time. One 
replicate plate experiment was performed for each evolved strain at 20k and 50k 
generations, and 4 replicates were run for each ancestor (REL606 and REL607). 
Tests for tradeoffs for the evolved strains as a group on a substrate had were 1-
sample T-tests against the ancestral distribution with significance cutoff of 
P=0.002 to adjust for multiple comparisons. Tests for individual strains were the 
same but with a cutoff of P=0.0005. 
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Flux Balance Analysis 
Flux analysis was carried out with a genome-scale model of E. coli metabolism 
(iAF_1260 [58]). The model incorporates 2382 reactions and 1668 metabolites. 
The default minimal media environment and reaction bounds were used. Fluxes 
were predicted for each individual carbon source provided, normalized by 
number of carbon atoms to 10 units of glucose. Maximal biomass per substrate 
was used as the objective criterion as previously[15]. To determine whether a 
reaction was necessary for optimal growth on a substrate, each reaction flux 
predicted was individually constrained to zero. Only the necessary reactions, 
those for which constraining the flux resulted in a reduction in final biomass, 
were considered in the analysis of differences between flux vectors 
(Supplementary Table 3.2). Reaction differences between substrates, considered 
for the Hamming distance, are listed in Supplementary Table 3.3. Supplementary 
Table 3.4 summarizes alternative distance metrics that were used to assess the 
difference between flux vectors. 
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The most powerful genome-scale framework to model metabolism, flux balance 
analysis (FBA), is an evolutionary optimality model. It hypothesizes selection 
upon a proposed optimality criterion in order to predict the set of internal fluxes ! 80!
that would maximize fitness. Here we present a direct test of the optimality 
assumption underlying FBA by comparing the central metabolic fluxes predicted 
by multiple criteria to changes measurable by a 13C-labeling method for 
experimentally-evolved strains. We considered datasets for three Escherichia coli 
evolution experiments that varied in their length, consistency of environment, 
and initial optimality. For ten populations that were evolved for 50,000 
generations in glucose minimal medium, we observed modest changes in relative 
fluxes that led to small, but significant decreases in optimality and increased the 
distance to the predicted optimal flux distribution. In contrast, seven populations 
evolved on the poor substrate lactate for 900 generations collectively became 
more optimal and had flux distributions that moved toward predictions. For 
three pairs of central metabolic knockouts evolved on glucose for 600-800 
generations, there was a balance between cases where optimality and flux 
patterns moved toward or away from FBA predictions. Despite this variation in 
predictability of changes in central metabolism, two generalities emerged. First, 
improved growth largely derived from evolved increases in the rate of substrate 
use. Second, FBA predictions bore out well for the two experiments initiated with 
ancestors with relatively sub-optimal yield, whereas those begun already quite 
optimal tended to move somewhat away from predictions. These findings suggest 
that the tradeoff between rate and yield is surprisingly modest. The observed 
positive correlation between rate and yield when adaptation initiated further 
from the optimum resulted in the ability of FBA to use stoichiometric constraints ! 81!
to predict the evolution of metabolism despite selection for rate. 
 
Introduction 
Systems biology is beginning to provide insight into how interactions within 
complex networks give rise to the holistic behavior of biological systems, and how 
natural selection would shape these systems over the course of adaptation. Some 
mathematical models are made with the goal of translating known parameters of 
components of a small system into predictions of their function. This approach 
has been used to predict behavior ranging from the oscillation of natural or 
engineered genetic regulatory networks [1] to flow through small metabolic 
networks [2,3]. For larger, genome-scale networks there is insufficient 
information to generate direct predictions in the same manner. Instead, one can 
ask how the system should behave were it to have already been selected to 
function optimally given tradeoffs between different selective criteria. One use of 
mechanistically-explicit optimality models is to consider the possible optimality 
of current biological phenomena, such as the optimality of the genetic code [4] or 
of the enzymatic properties of RuBisCO [5]. On the other hand, optimality 
models can also be used directly to predict phenotypic changes in a system that 
would occur over the course of adaptation, such as the evolution of virulence [6] 
or enzyme expression [7]. 
 
The most broadly applied metabolic modeling framework, Flux Balance Analysis ! 82!
(FBA), is a constraint-based evolutionary optimality model. It quantitatively 
predicts flux through a metabolic network that will maximize a given criterion 
thought to represent prior natural selection [8]. At the heart of FBA is a 
stoichiometric matrix, which is a mathematically transformed list of mass-
balanced biochemical reactions that fully describes the known topology of the 
metabolic network of a cell (or other system). It is further assumed that the cell is 
in a metabolic steady-state, such that the sum of fluxes in and out of each internal 
metabolite are balanced. As additional constraints are considered (e.g., maximal 
flux values, irreversible reactions, biomass composition), this matrix can then be 
used to help define and constrain the space of feasible flux distributions in the 
cell. Within this feasible space, linear programing is subsequently used to solve 
for an optimality criterion -such as maximal biomass per substrate (see below)- 
to identify a feasible flux distribution that permits that optimum.  
 
Evolutionary optimality models are powerful tools as they make it possible to 
build intuition about the forces that shape biological diversity. However, as has 
been pointed out most famously by Gould and Lewontin, they can also be 
misleading and can foster the wrong intuitions [9]. Optimality models make three 
assumptions: 1) selection (and not other processes) is the primary evolutionary 
force shaping a trait of interest, 2) we can identify the criterion upon which 
selection is acting, and 3) there are not underlying constraints which prevent a 
trait from being optimized. Optimality models are constructive for understanding ! 83!
the evolution of traits only to the extent that these assumptions can be evaluated. 
 
FBA provides an excellent framework to generate testable hypotheses as to which 
selective criteria are appropriate for a given set of conditions [10,11]. In 
environments such as batch culture, selection acts directly upon growth rate -as 
well as lag and survival in stationary phase- but not upon yield [12]. The most 
common optimality criterion for FBA is commonly referred to as maximizing 
growth rate [11]. Because this is performed by constraining one (or occasionally 
multiple) substrate uptake rate (S/time), this criterion is fully equivalent to 
predicting the maximum yield (i.e., BM/S) under the given, user-supplied 
substrate uptake rate. Since FBA cannot predict absolute rates of substrate 
uptake used as the key constraint, the question as to whether adaptation would 
optimize BM/S during batch culture critically depends upon the correlation 
between growth rate and yield. There are solid theoretical grounds to expect 
absolute limits to the maximization of both rate and yield of reactions [13], but it 
is often unclear how close biological systems are to these constraints.  
 
In addition to maximization of biomass, various other cellular objectives have 
been suggested as alternative selective criteria. These include optimal energetic 
(rather than biosynthetic) efficiency whereby generation of ATP per substrate 
(ATP/S), or the minimization of the sum of fluxes (BM/Σv or ATP/Σv). The latter 
are based upon the rationale that enzymes are costly, and thus a general ! 84!
relationship between enzyme levels and reaction rates (although actually quite 
weak for any given enzyme, [14]) would lead to selection to minimize the total 
burden of enzymes needed. Finally it has been suggested that selection acts 
simultaneously upon multiple, competing criteria, leading cells to inhabit an 
optimal tradeoff surface known as a Pareto optimum [15,16]. This approach 
constructs a surface on which no single criteria can be further increased without 
reducing another. It is then assumed that evolution pushes biological systems to 
exist somewhere on this surface. Data from a variety of experiments suggested 
that cells operate near to the Pareto optimum defined by BM/S, ATP/S, and 
minimization of Σv [15]. 
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Figure 4.1: Evolution of metabolic fluxes and measures of optimality 
and predictability. We consider three ways to analyze changes in metabolism 
that relate an ancestor (Anc, blue) to an evolved isolate (Ei, green) in regard to an 
FBA-predicted optimum (Opt, red). A) Evolution of metabolic fluxes can be 
evaluated from the perspective of changes in proximity to the theoretical 
maximum for a given optimality criterion (Δ% Optimality). B) A vector of flux 
ratios defines a position in multi-dimensional flux space. One can then consider 
the relative Euclidian distance of a given evolved population in this space from its 
optimum (DEO) compared to that of an ancestor from its optimum (DAO; plotted 
as log(DEO/DAO)). C) At the most detailed level, one can compare the FBA-
predicted value for a given flux ratio versus that observed via 13C labeling. 
 
Tests of the predictive capacity of FBA have differed in two ways depending upon: 
1) whether there was known or assumed adaptation to the substrate in question, 
and 2) whether tests were a direct or indirect comparison of predicted internal 
fluxes to measured fluxes (Table 4.1). The majority of these tests have been ! 86!
conducted with Escherichia coli, and have assumed past selection on BM/S. The 
direct tests of FBA compared predicted to observed flux distributions (Figure 4.1) 
by taking advantage of empirical data generated by 13C-labeling techniques [17]. 
Briefly, this method to assay relative metabolic fluxes takes advantage of the fact 
that the carbon atoms of the growth substrate are shuffled in different ways by 
alternative metabolic pathways, and that these rearrangements leave a signature 
in biomass. Using gas chromatography-mass spectrometry (GC-MS) to determine 
the 13C-labeling of protein-derived amino acids, it becomes possible to infer the 
flux splits in the metabolic pathways leading to their synthesis [17–23]. Notable 
amongst these tests was a quantitative assessment of the relative merits of a 
series of optimality criteria (and constraints) in their ability to predict the 
intracellular fluxes of E. coli measured in six environments [11]. Data for wild-
type cultures indicated that ATP/Σv2, BM/S or ATP/S were more predictive 
depending upon the growth condition; however, in all cases there was still 
significant variation between predicted and measured fluxes.  
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Past 
adaptation 
Test of 
internal 
fluxes  Major approaches 
Example 
papers 
Assumed   Indirect  Growth rate and excretion.  Varma & Palsson, 
1994 
Growth phenotypes or gene 
essentiality of knockouts. 
Raghunathan et al, 
2009 
Direct  Comparison of wild-type or 
knockout flux pattern to mutants in 
one or more environments, usually 
using just BM/S or ATP/S as an 
optimality criterion. 
Emmerling et al, 
2002 
 
Explicit comparison of E. coli fluxes 
across environments to predictions 
from multiple optimality criteria. 
Schuetz et al, 2007 
Known  Indirect  Uptake, excretion, and/or growth 
rates for evolved strains. 
Ibarra et al, 2002; 
Teusink et al, 2009 
mRNA and protein levels correlated 
with predicted pathways in FBA. 
Fong et al, 2005; 
Lewis et al, 2010 
Direct  Flux changed during adaptation of 
E. coli evolved with key metabolic 
knockouts or on the poor substrate 
lactate, but no comparison made to 
FBA. 
Fong et al, 2006; 
Hua et al, 2007 
Flux changes during adaptation of E. 
coli to a fluctuating environment 
compared to predictions of a Pareto 
surface. 
Schuetz et al, 2012 
Flux measurements following 
50,000 generations of E. coli 
adaptation and comparison of this 
and other datasets to FBA. 
This study 
Table 4.1: Major approaches to test of FBA predictions depending 
upon whether there was known selection under experimental 
conditions and whether there was direct measurement of internal 
fluxes. ! 88!
A key advance in the use and testing of FBA came from the realization that the 
best test of an optimality model is to examine whether there is movement toward 
predicted optimal phenotypes following adaptation under known experimental 
conditions (Table 4.1). In a classic paper, populations of E. coli were adapted to 
various carbon substrates for 100-700 generations [24]. The authors ran FBA for 
all pairwise constraints of substrate and oxygen uptake to predict the maximal 
BM/S within those constraints, and what metabolites might be excreted. 
Remarkably, adaptation on five out of six substrates conformed to the predictions, 
remaining on or evolving toward a ‘line of optimality’ representing the optimal 
oxygen to substrate ratio. For only one of these substrates did the population 
move away from the predicted optimality. A follow-up study further showed that 
the genes expressed in evolved lines correspond to the fluxes predicted to be 
active by FBA [25]. Since flux changes are only sometimes well-correlated with 
gene expression [26], however, it remains unclear whether FBA can predict the 
change in internal fluxes. Although indirect, these studies have suggested that 
FBA might reasonably capture the evolutionary forces acting on cellular 
physiology and hence would be capable of predicting the outcome of evolution 
[27]. 
 
To our knowledge there have been only two studies in which the internal fluxes 
have been measured for both ancestral and evolved strains grown in a constant 
environment with a single growth substrate. Both involved rapid, short-term ! 89!
adaptation (<1,000 generations) of E. coli under conditions where the cultures 
were kept in continual exponential growth in batch culture by using frequent, 
large dilutions. Hua et al [28] measured fluxes following adaptation to the 
poorly-utilized substrate lactate, while Fong et al [20] measured fluxes following 
adaptation of a series of E. coli strains with knockouts (KOs) deleting individual 
enzymes of major branches of central carbon metabolism (e.g., glycolysis). 
Interestingly, both studies found rather divergent changes in flux distribution 
across replicates, and found that most improvement in growth rate was the result 
of increases in substrate uptake. These studies were not compared to FBA 
predictions, however, thus it remains unclear whether the assumed optimality 
criteria improved, or whether observed intracellular fluxes moved toward those 
predicted with a genome-scale FBA model. 
 
In terms of using experimental evolution to test optimality, the cultures that have 
had the greatest time to adapt are those from the E. coli long-term experimental 
evolution (LTEE) populations that have been evolving in the Lenski laboratory 
for over 50,000 generations [29,30]. These twelve replicate populations have 
evolved in minimal medium with glucose since 1988, experiencing 100-fold daily 
dilutions that result in a short lag phase, nearly seven consecutive generations in 
exponential phase, and then stationary phase. The LTEE experiment has enabled 
an unprecedented examination of genotypic and phenotypic change over an 
extended period of adaptation [29,31]. Despite starting with a wild-type strain ! 90!
capable of rapid growth on glucose, all populations have increased dramatically 
in both growth rate and competitive fitness through adaptation in batch culture 
[32,33]. It should be noted however, that batch culture inherently incorporates 
some non-steady state conditions and that improvements in lag or survival may 
have had pleiotropic consequences for growth. Despite this, here we ask how well 
FBA predictions align with the evolved changes in these populations. If FBA is 
unable to predict adaptation to single-nutrient, seasonal batch culture conditions 
we will not be able to apply it to most laboratory environments, not to mention 
the variable habitats experienced in nature. 
 
The goal of the current work was to test whether the central metabolic fluxes of 
replicate populations of E. coli with known selective history in the laboratory 
evolved in a manner that is predictable by FBA (Figure 4.1). We compared the 
fluxes inferred from 13C labeling to the ranges predicted to permit optimal 
performance and summarize these changes in three ways: the % optimality 
possible given the inferred fluxes, the minimal distance in flux space between the 
inferred fluxes and the optimal space of distributions, and a flux-by-flux 
comparison to see how each flux changed relative to predictions. Testing the 
ability of optimality criteria to predict adaptation not only provides insight into 
the mechanisms of evolution, but also represents a critical test of the central 
optimality assumption of FBA. The LTEE lines began with an ancestor operating 
at near-optimal BM/S, but the independent populations evolved to use central ! 91!
metabolism less optimally. This was reflected in both a small, but statistically 
significant, decrease in the % optimal BM/S, and a corresponding increase in the 
distance from the observed to optimal flux state. In contrast, the seven lactate-
evolved populations evolved to increase BM/S and moved closer to an optimal 
flux distribution. The three pairs of KOs had mixed results in terms of optimality 
and flux pattern. Overall these results indicate that evolved increases in growth 
rate largely resulted from increased substrate uptake. Furthermore, ancestral 
strains operating far from optimal yield evolved as suggested by FBA, whereas 
those close to the optimum experienced a modest decrease in optimality and 
evolved to be further from FBA predicted fluxes than their ancestor.  
 
Results 
 
Growth rate, cell dry weight and carbon uptake all increased after 50,000 
generations of adaptation on glucose minimal medium 
 
Prior to measuring internal metabolic fluxes, we first examined key growth 
parameters for one isolate from the 50,000 generation time-point for each of 10 
independent LTEE populations (Supplementary Table 4.1). Growth rate 
increased by 45% on average (Supplementary Table 4.1), which is concordant 
with the 16% increase observed in these lines after 2,000 generations [32], and 
the 20% increase measured after 20,000 generations [33]. All evolved lines also ! 92!
increased their glucose uptake rates (individually significant for 5 of 10 lines: A+3, 
A-2, A-4, A-5, A-6; T-test, p < 0.05, two-sample, equal variance throughout 
unless noted otherwise, Supplementary Table 4.1), with an average increase of 
18%. The cell dry weight per gram of glucose also increased by an average of 20% 
while max OD600 increased by 68%. This did not come from decreasing their 
excretion of organic acids, however, as acetate production actually increased by 
an average of 50%. No other excreted ions were observed above our limit of 
detection of ~50 µM (Supplementary Table 4.1).  
 
LTEE isolates have modest, but significant changes to their relative central 
metabolic flux distribution 
In order to determine whether the improved performance of the LTEE isolates 
was reflected in changes in the relative use of central metabolic pathways, we 
used 13C-labeling of protein-derived amino acids [17] to infer several key flux 
ratios in central carbon metabolism (Figure 4.2A). Often the goal is to extrapolate 
from the measured flux ratios to calculate the flux for each reaction in a network 
[15,23]. For this study, however, we limit our discussion and analyses to the flux 
ratios themselves, as these represent the actual number of inferences from the 
13C-labeling data and thus each cellular branch-point is given equal weight 
(Supplementary text 3.1). It should be noted that 13C data for the LTEE isolates 
were analyzed with a program, FiatFlux [17], which is based on a simplified 
model of central carbon metabolism. This program was used for the previous ! 93!
study comparing alternate optimality criteria mentioned above [11], as well as for 
obtaining the flux data about the lactate [28] and KO [20] lines we analyze below. 
Inferences with this commonly used program are less variable than inferences 
based on larger models [34]. 
 
Figure 4.2: Evolved changes in central carbon metabolism for the 
LTEE populations after 50,000 generations of adaptation on glucose. 
A) The flux pathways measured for the LTEE lines are denoted with numbers and 
red arrows. The genes knocked out in the knockout data set and the entry point of ! 94!
Figure 4.2, continued: lactate into the network are both indicated. B) A heat 
map of the difference between evolved and ancestral flux ratios from the LTEE 
populations. The right side indicates flux ratios predicted for the ancestral line 
according to each optimality criterion. The number of the flux ratio corresponds 
to the numbered pathways in A. Single asterisks denote significant changes as 
calculated by ANOVA, double asterisks are also significant by Tukey-HD. 
 
We uncovered statistically significant, but modest variation in the flux ratios of 
evolved isolates relative to their ancestor (Figure 4.2B, Supplementary Table 4.2). 
In terms of the overall pattern, a MANOVA test found that flux ratios changed 
significantly as a function of population (Pillai’s Trace = 3.80, p<0.001, 
Supplementary Figure 4.1). Additionally, ANOVA tests on the flux ratios for 
individual lines found at least one significantly different isolate (p < 0.05) for all 
ratios except two, and all lines had significant change in at least one flux ratio. A 
joint linear regression of the populations found 22 fluxes that differed from the 
ancestor at a p ≤ 0.05. The False Discovery Rate (FDR) metric suggests that 18 
more significant changes were found than expected by chance, whereas the more 
conservative Tukey HSD test finds that 10 flux changes remain significant. 
 
A few patterns emerged in terms of the actual fluxes found to have changed in 
evolved isolates. First, the most parallel change was that a small, but significant 
portion of glucose was routed through the Entner-Doudoroff pathway (Figure 4.2, ! 95!
flux 2). In all but one case this was accompanied by a similar decrease in the 
proportion of carbon flowing through the pentose-phosphate pathway (flux 3). 
On the other hand, replicate lines evolved in opposite directions for flux through 
glycolysis (flux 1), and for the fluxes producing oxaloacetate from 
phosphoenolpyruvate (fluxes 4). Additionally, in all cases there was no significant 
change in the lower bound of production of pyruvate from malate via malic 
enzyme (flux 6) across evolved isolates. 
 
Long-term evolution on glucose did not increase any optimality criterion  
 
As a first step in testing the validity of different optimality criteria, we asked 
whether the flux ratios observed in evolved isolates led to increased or decreased 
performance with regard to each criterion (Figure 4.1A). The ‘% optimality’ can 
be calculated by comparing the maximum value of a criterion when the model 
was constrained with the observed flux ratios and substrate uptake rate to the 
maximum value of the criterion in the absence of the flux ratio constraints. Note 
that because this metric simply compares values of given optimality criteria 
rather than a particular set of flux ratios it is not affected by the existence of 
alternate optima for some fluxes. 
 
There was a slight (0.8%) but significant drop in the average percent optimal 
biomass production (BM/S; T-test, p=0.008), with 9 of the 10 evolved lines ! 96!
decreasing relative to the ancestor (Figure 4.3A). Turning to alternative 
optimality criteria, we first found that ATP/S did not change significantly (Figure 
4.3D), though unlike all other measures throughout, the output was not normally 
distributed (Shapiro-Wilk test of residuals, p = 0.002; for rest see Figures S2 and 
S3). Correspondingly, significance for changes in this criterion was tested with 
the non-parametric Mann-Whitney-Wilcoxon Rank Sum Test (p = 0.79). BM/Σv 
and ATP/Σv behaved qualitatively similarly to BM/S and ATP/S, respectively, but 
as neither change was significant these results are displayed only in 
supplementary material (Supplementary Figure 4.4). Finally, we calculated the 
nearest possible flux distribution for each evolved isolate to the Pareto optimum, 
and found that 9 of 10 isolates were further from an optimal tradeoff between 
criteria than the ancestor (Supplementary Figure 4.5). ! 97!
 
Figure 4.3: Measures of optimality and predictability after adaptation 
of LTEE populations to glucose for 50,000 generations. A,D) The % 
optimality of the ancestor (black) and evolved isolates (grey, same order as Fig. 
2); B,E) distance to optimal flux distribution (plotted as log(DEO/DAO)); and C, F) 
comparison of predicted to observed flux ratios for FBA-predictions based upon 
BM/S (A-C) or ATP/S (D-F). Error bars represent standard errors of three 
biological replicates. ! 98!
In order to test the sensitivity of these findings to assumptions made in using 
FBA, we compared the effect of changing the values used for O2 limitation, 
maintenance energy, and the possible change in biomass composition that would 
result from the documented increase in average cell size [12]. None of these 
modulations changed the qualitative results and generally the default values 
outperformed the others (Supplementary Figures 3.6 and 3.7). Therefore, the 
conclusion that adaptation did not lead to an increase in any optimality criterion 
for the LTEE populations seems rather robust. 
 
Long-term glucose evolution resulted in movement of the flux distribution away 
from predicted states 
 
We next examined whether the flux distributions we inferred for the LTEE 
isolates moved toward (or away) from the flux distribution predicted to result 
from optimizing each criterion. We calculated the distance to the optimal fluxes 
for each evolved isolate relative to the distance between the ancestor and 
optimality (Figure 4.1B). Because the per-substrate criteria (e.g., BM/S, ATP/S) 
had many equally-optimal flux distributions, we identified the optimal solution 
that minimized the Euclidean distance from observed flux ratios. Choosing the 
FBA solution that is the closest to our empirical flux observations should, if 
anything, bias in favor of FBA.  
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Beginning with the overall pattern of fluxes, we quantified the log ratio of evolved 
to ancestral flux distance to their nearest optimum (Figure 4.1B). Both BM/S and 
ATP/S predicted optima in the opposite direction of the evolutionary flux 
movement, and hence evolved lines ended up significantly farther from optima 
than the ancestor (Figures 3.3B,E; S2; BM/S, T-test p=0.0008; ATP/S, T-test, p 
= 0.0004). In both cases the movement away from the optimum was primarily 
driven by changes in the flux of oxaloaceate from phosphoenolpyruvate.  
 
Turning to individual flux ratios, no criterion fared particularly well (Figure 4.2B, 
3C,F). None correctly predicted the observed increased flux through the Entner-
Doudoroff pathway, nor the trend of reduced oxaloacetate from 
phosphoenolpyruvate in evolved lines. 
 
Metabolic changes in E. coli evolved on the poor substrate lactate were well-
predicted by FBA using BM/S as an optimality criterion 
 
A second data set we considered was the seven populations of E. coli that evolved 
on the poorly-utilized substrate lactate for ~900 generations [28]. These 
populations improved in growth rate and cell dry weight substantially (112% and 
50%, respectively) in addition to increasing lactate uptake by 40% [28].  
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Figure 4.4: Measures of optimality and predictability after adaptation 
to lactate for ~900 generations. A,D) The % optimality of the ancestor 
(black) and evolved isolates (grey); B,E) distance to optimal flux distribution 
(plotted as log(DEO/DAO)); and C, F) comparison of predicted to observed flux 
ratios for FBA-predictions based upon BM/S (A-C) or ATP/S (D-F).  ! 101!
We found that adaptation to growth on lactate led to a significant increase of 8% 
in the predicted percent optimal BM/S (Figure 4.4A; T-test, p = 0.02), whereas 
the % optimal ATP/S decreased significantly (Figure 4.4D; T-test, p = 0.01) by 7%. 
The % optimality for BM/Σv and ATP/Σv again qualitatively followed the 
respective per substrate criteria (Supplementary Figure 4.4). Similarly, fluxes 
moved closer to the state predicted by BM/S by an average of 20% (Figure 4.4B; 
T-test, p = 0.005), largely as the result of changes in the predicted and observed 
flux to acetate (Figure 4.4C,F). In contrast, they moved away from the state 
predicted by ATP/S (Figure 4.4E; T-test, p = 0.0004). Additionally, 6 of the 7 
lactate populations evolved to be further from the Pareto optimal surface than 
their ancestor (Supplementary Figure 4.5). 
 
E. coli central metabolic knockouts did not evolve in the direction of FBA 
predictions 
 
As a third test of whether strains evolve in a manner consistent with FBA 
predictions, we considered the results from evolution on glucose for KO 
populations with lesions in central metabolism (see Figure 4.2A). These data 
come from two populations each initiated with strains lacking phosphoglucose 
isomerase (Δpgi), triose-phosphate isomerase (Δtpi) or phosphoenolpyruvate 
carboxylase (Δppc) and evolved for ~800, ~600, and ~750 generations 
respectively [20]. Considering the improvement of these populations jointly, they ! 102!
increased in both growth rate and glucose uptake (172% and 157%), had large 
changes in central metabolic fluxes, but were largely unchanged in dry cell weight 
(3%). For analyzing changes in their metabolic fluxes, however, we do not present 
statistical tests of significance given that we only have two observations for each 
of these three ancestors. 
 
Our analysis of the flux data indicated that, for BM/S, Δpgi, and Δtpi strains got 
worse while Δppc strains improved their % optimality (Figure 4.5A). This pattern 
largely held for ATP/S as well, though Δtpi strains showed essentially no change 
in % optimality (Figure 4.5C). The KO data set is the only one in which 
minimizing Σv led to qualitatively different behavior from the per substrate 
analyses. Minimizing flux led to increases in the % optimality for Δpgi and Δtpi 
when using BM/Σv as a criterion (Supplementary Figure 4.4). 
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Figure 4.5: Measures of optimality and predictability after adaptation 
of gene knockouts on glucose for ~600-800 generations. A,B) The % 
optimality of the ancestor (black) and evolved isolates (grey); C,D) distance to 
optimal flux distribution for FBA-predictions based upon BM/S (A,C) or ATP/S 
(B,D).  
 
Evolution pushed strains further away from optima in all cases except Δpgi as 
predicted by BM/S (Figure 4.5B,D). Reduced distance to the optima for Δpgi was 
driven by reduction in the flux from oxaloacetate to phosphoenolpyruvate in 
evolved lines. Finally, the two Δpgi evolved isolates evolved to be more Pareto 
optimal, the Δtpi isolates were essentially equivalent to their ancestor, and the ! 104!
Δppc isolates became less Pareto optimal (Supplementary Figure 4.5). 
 
Discussion 
Genome-scale metabolism is sufficiently complex that the current state of the art 
in predictive models uses stoichiometry and other constraints to define the space 
of possible flux patterns and then suggests a given state that the cell would adopt 
if selection had maximized a proposed optimality criterion. The application of a 
mechanistic evolutionary optimality model to propose a solution to an 
underdetermined physiological problem is elegant and has been adopted broadly. 
However, there is a paucity of data testing either the central assumption that 
intracellular fluxes are optimized by a simple criterion, or which criterion best 
represents the target of selection. Here we present an analysis of metabolic 
evolution in the Lenski LTEE populations and make the first direct comparison of 
observed flux evolution to genome-scale FBA predictions. 
 
Our analysis of the evolution of metabolic fluxes during 50,000 generations of 
adaptation of E. coli on glucose revealed changes in both the absolute and relative 
fluxes. Concordant with faster growth rates, we observed that all lines had 
increases in measured glucose uptake. Beyond this, all populations altered the 
way in which they utilize glucose, with significant changes in flux ratios observed 
across the network of central carbon metabolism. The most parallel changes in 
flux distribution were observed in the glycolytic pathways with a universal small, ! 105!
but significant increase in flux through the Entner-Doudoroff pathway, which 
was nearly always accompanied by a decrease through the pentose phosphate 
pathway. This is somewhat perplexing, as the Entner-Doudoroff pathway 
provides less ATP than glycolysis and no important biosynthetic intermediates. 
The Entner-Doudoroff pathway is shorter than glycolysis, and hence potentially 
less enzymatically costly. Indeed, what maintains the pathway in E. coli remains 
an open question, though it has been observed to be upregulated in E. coli during 
long-term starvation [35].  
 
The major basis of improvement during selection upon growth rate for the LTEE 
populations –as was observed for the lactate and KO populations– came from 
increasing substrate uptake. We found that the LTEE populations continued to 
increase their growth rate over the 30,000 generations since it was last reported 
[33]. Alternative measures of yield, such as cell dry weight and OD600, also 
increased despite the slight decrease in efficiency of biomass production by 
central metabolism. Cell dry weight depends upon both BM/S in terms of carbon, 
but can also change due to the relative biomass composition of elements such as 
nitrogen or phosphorus. OD600 is even more indirect, depending upon all of these 
factors as well as changes in optical properties such as cell size, which is known to 
have increased in the LTEE [32]. We only measured flux ratios in central carbon 
metabolism, and thus would have missed significant adaptation that happened in 
peripheral metabolic pathways. Alternatively, either the bulk composition of ! 106!
biomass itself or the maintenance energy might change. We addressed these 
latter two factors in additional analyses (Supplementary Figure 4.7), but neither 
of these factors significantly alters results.  
 
Data on the evolution of central metabolism for the LTEE populations, combined 
with prior observations of flux evolution on lactate or by a series of three KO 
strains provided the opportunity to test several facets of whether the direction of 
evolutionary change was consistent with FBA predictions.  
 
Across experimental systems we ascertained which proposed optimality criteria 
are most often consistent with the observed evolution in central metabolism. On 
average across five different ancestors, BM/S outperformed the other criteria in 
terms of either increasing or going unchanged (Supplementary Figure 4.8). The 
most dramatic example was seen for the lactate-evolved populations, for which 
BM/S increased while ATP/S decreased. The per flux criteria (BM/Σv and 
ATP/Σv) behaved qualitatively the same as the per substrate criteria in all but 
two of the cases (Δpgi and Δtpi). BM/Σv outperformed BM/S in these two cases, 
but, for example, did not significantly improve in the lactate populations. The 
data also suggest that cultures quite often evolved to be further from their Pareto 
optimum representing the space of optimal tradeoffs [15], with 19 of 23 
populations in total moving further from the Pareto surface than their respective 
ancestral genotypes. These results suggest that optimal biomass yield –which is ! 107!
the most commonly utilized criterion for FBA– was the best overall 
stoichiometric proxy for cultures where selection was directly upon growth rate. 
It will be quite interesting to analyze populations grown in a manner where yield 
(BM/S) is directly selected. 
 
Overall, approximately half of the flux data were consistent with FBA predictions, 
and half refuted the common assumption that evolution acts to optimize 
efficiency; what accounts for this discrepancy? The major factor that appears to 
account for this difference is the initial degree of optimality for the ancestor of 
the evolved lines (Figure 4.6). For the lactate and Δppc populations, which began 
at approximately 80% and 90% optimality for BM/S, all 9 total replicates 
increased in BM/S. On the other hand, 13 of 14 populations starting at or above 
95% efficiency –LTEE and the other two KOs– decreased in BM/S. A negative 
correlation holds whether one performs a parametric statistical test (Pearson 
correlation, p < 0.0001) or a non-parametric Spearman correlation coefficient (p 
< 0.0001), though it should be noted that the strength of the correlation is largely 
driven by the lactate data set. ! 108!
 
Figure 4.6: Evolutionary change in % optimality versus initial % 
optimality of the ancestor across data sets for BM/S. Error bars 
represent standard errors between evolved populations. 
 
The finding that selection on optimal efficiency depends on distance to the 
optimum is both of practical and fundamental interest. The analysis represents 
the first direct demonstration that FBA can be used to predict changes in 
intracellular metabolism that result from adaptation on a single carbon source. 
This positive result comes with the caveat that strains must begin far from the 
optimum. Systems initially operating at high yield –like the LTEE and the Δpgi 
strains that both began above 98% optimal– may end up evolving to be further 
from optimal than they began. In other words, this suggests one can either 
predict the initial physiological state or the direction of evolution, but not both. ! 109!
 
What is perhaps the most remarkable about these findings is that even for 
cultures with a negative correlation between rate and yield, the tradeoff was quite 
modest. Small decreases in BM/S were more than made up for by large increases 
in uptake, leading to a net increase in growth rate despite mild antagonism. 
Given that there is no direct selection upon yield during batch culture, this 
perhaps suggests the existence of constraints upon the further improvement of 
substrate uptake. As long as uptake is held constant then changes in yield would 
directly translate into changes in growth rate. As such, this would maintain 
purifying selection upon yield, even over 50,000 generations. On the other hand, 
the low efficiency ancestors were able to evolve both improved substrate uptake 
and yield simultaneously.   
 
Although FBA is typically applied as a practical tool to guide experiments –and it 
has had some remarkable successes, such as correctly predicting a rather 
unexpected new metabolic pathway in some cancers [36]– it also serves as a 
quantitative, testable, falsifiable model that connects physiology to evolution. The 
interplay of optimality models and laboratory adaptation will be critical as the 
field continues to move toward a fuller understanding of the selection and 
constraints that act upon biochemical networks.  
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Materials and Methods 
Strains and growth conditions during selection 
 
Escherichia coli B isolates were obtained from the Lenski LTEE experiment [29] 
after 50,000 generations. Briefly, 12 populations of E. coli were founded with 
either the arabinose-negative strain REL606 (populations A-1 to A-6) or the 
arabinose-positive derivative, REL607 (A+1 to A+6). These were evolved in 10 
mL of Davis-Mingioli minimal medium with 139 µM glucose (25 mg/L) as a 
growth substrate in 50 mL flasks since 1988. These lines have been cultured at 
37 °C while shaking at 120 rpm and have been transferred daily via 1:100 
dilutions (~6.64 net doublings per day). 
 
The isolates analyzed in the current experiment consisted of the ancestral line, 
REL606 [29], as well as the ‘A’ clone from 10 of the 12 lines frozen at 50,000 
generations that were used in an earlier paper (A-1 = REL11330; A-2 = 
REL11333; A-4 = REL11336; A-5 = REL11339; A-6 = REL11389; A+1 = 11392; 
A+2 = REL11342; A+3 = REL11345; A+4 = REL11348, A+5 = REL11367)[30]. The 
A-2 clone used is from the ‘large’ lineage that has coexisted with a cross-feeding 
‘small’ lineage for tens of thousands of generations [37]. The isolate from the 
citrate-consuming population A-3 (REL11364) was not used because it adapted to 
citrate consumption in addition to glucose [38]. The A+6 isolate (REL11370) was 
excluded from analysis because it had inconsistent growth, and gave irregular ! 111!
flux data. This population was previously excluded from a study of growth rate vs. 
yield at 20,000 generations for similar reasons [13].  
   
Measurement of key metabolic flux ratios 
 
Flux measurements were obtained based on the methods of Zamboni et al [17]. 
Evolved isolates were grown in 150 mL of Davis-Mingioli minimal media with 139 
µM glucose without sodium citrate (excluded to ensure that it was not used as a 
secondary carbon source by any line). In order to obtain information from 
different parts of central metabolism, 13C-labeling either utilized a 20:80 ratio of 
[U-13C]labeled:unlabeled glucose or 100% [1-13C]glucose (Cambridge Isotope 
Laboratories, Andover, MA). The ancestral REL606 was grown in 200 mL to 
obtain sufficient cell material. At mid-log phase (60-80% max OD) all cells were 
pelleted from the media, hydrolyzed overnight in 6 M HCl, and dried. The dry cell 
material was then derivatized for an hour at 85 °C with 40 µL each of 
dimethylformamide and N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide 
with 1% tert-butyldimethyl-chlorosilane. The derivatized cell material was 
injected into a Shimadzu QP2010 GCMS (Columbia, MD). The injection source 
was 230 °C. The oven was held at 160 °C for 1 min, ramped to 310 °C at 20 °C 
min-1, and finally held at 310 °C for 0.5 min. Flow rate was 1 mL min-1 and split 
was 10. The column was a 30 m Rxi-1ms (Restek, Bellefonte, PA). Three technical 
and three biological replicates were run for each isolate. ! 112!
 
Data files from the GC-MS were analyzed in FiatFlux [17], as had been used for 
the lactate [28] and KO [20] populations we also analyzed. The data conversion 
files were rewritten to load the raw spectra produced by our MS. Following the 
established protocol, uninformative amino acid fragments were removed. Means 
for each biological replicate were calculated from the average of three technical 
replicates. Shapiro-Wilk tests were used to validate the assumption of normally-
distributed errors for estimated flux ratios for each strain (Figures S2, S3). 
Variance in flux ratios was then analyzed with a MANOVA test using the Pillai’s 
Trace metric with flux ratios entered as separate dependent variables 
(Supplementary Figure 4.1). Univariate ANOVA tests were also run to investigate 
which of the measured flux ratios changed significantly for individual strains.  
 
The flux of oxaloacetate (OAA) from phosphoenolpyruvate (PEP) was further 
estimated by a Monte-Carlo method to determine the contribution of the 
glyoxylate shunt. The method follows Waegeman et al, 2011 [23] and uses 
MATLAB code they kindly provided. In short, average mass distribution vectors 
and standard deviations were calculated from the measured samples. The 
‘normrand’ function was then used to randomly draw from these mean 
distributions 1000 times. For each draw, a grid search was used to find the flux 
ratios that best fit the mass distribution vectors. Substantial variation was found 
for the fraction of labeled CO2 and flux through the glyoxylate shunt, but in all ! 113!
cases there was very strong support for the flux ratio of oxaloacetate from 
phosphoenolpyruvate that had previously been calculated by FiatFlux. 
 
Physiological measurements of growth rate, cell dry weight, glucose uptake and 
acetate excretion 
 
Uptake and production of cell material were determined in a separate set of 
experiments. In these experiments glucose concentrations were increased ten-
fold to 1.39 mM so that enough of the compounds would be present to measure 
precisely. A volume of 250 µL of overnight culture was inoculated into 50 mL of 
media grown in a 250 mL flask at 225 rpm. Growth rate was determined by 
fitting a logarithmic model to OD600 measurements. A 10 mL sample was 
removed at early (OD600 of 0.090-0.120) and late (OD600 of 0.275-0.400) log 
phase. Cells were immediately removed from the media by passage through a 0.2 
µM filter. Glucose concentrations were determined in the spent media using a 
glucose oxidase assay kit (Sigma, Saint Louis, MO). Acetate concentrations were 
determined by ion chromatography with a Dionex ICS-200 RFIC. The flow rate 
was 1.5 ml/min and the column temperature was 30 °C. Cell dry weight (CDW), 
was measured as the mass of the pellet from 100 mL of fully-grown culture after 
overnight lyophilization. Three replicates were assayed for each measurement. 
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Calculation of variation in flux ratios across evolved isolates 
 
The degree of parallelism between replicates in the evolution of flux ratios was 
determined by calculating the coefficient of variation in flux ratios. For each flux 
ratio the standard deviation between evolved replicates was divided by the mean 
of that flux ratio. This value was then averaged across all flux ratios. Values close 
to zero indicate a high degree of similarity between evolved lines. 
 
Prediction of FBA optima 
 
Flux analysis was carried out with a genome-scale model of E. coli metabolism 
(iAF_1260 [39]). The model incorporates 2382 reactions and 1668 metabolites. 
Substrate uptake and excretion were constrained to that observed, otherwise the 
default minimal media environment was used. The lower bound on maintenance 
energy was left at the default value of 8.9 mmol ATP/g/hr. Oxygen uptake rates 
were set to those observed for the lactate strains; however these data were not 
available for the REL or KO strains. In these cases, oxygen uptake for the 
ancestor was scaled across the previously observed range of 11.5-14.75 
mmol/gCDW/hr [11]. Previous work demonstrated that oxygen uptake varies as a 
function of evolution, but that the ratio of substrate to oxygen usage remained 
largely constant [24]. Oxygen constraints for evolved lines were therefore set 
based on evolved glucose uptake rates and the ancestral ratio of oxygen/glucose. ! 115!
Changing the value of ancestral oxygen constraint, or the slope of constraint line 
had little qualitative effect (Supplementary Figure 4.6), so just the results based 
on an ancestral uptake of 14.75 mmol/g/hr and a slope maintaining the original 
oxygen/glucose rates are reported in the text. Gene knockouts were simulated by 
constraining flux through the missing gene to zero. 
 
For all data sets we systematically tested the predictive ability of four different 
optimality criteria: max biomass per unit substrate (BM/S), max ATP per unit 
substrate (ATP/S), max biomass per unit flux (BM/Σv) and max ATP per unit flux 
(ATP/Σv). These criteria relate to the best performers in Schuetz et al 2007 [11] 
and were defined as in that study. The per-substrate criteria maximized the 
criterion and then subsequently chose a flux distribution that minimized the 
difference from the observed isolate ratios.  This process always provides a flux 
distribution with maximal production of ATP (or biomass). The per-flux criteria 
optimize the ratio of ATP (or biomass) to the sum of the flux. Optimizing this 
ratio leads to a single optimal flux solution that often produces less than the 
maximal ATP (or biomass). For ATP criteria, flux to excess ATP use (via 
maintenance energy) was maximized while constraining the lower limit of 
biomass production to the ancestral growth rate. 
 
Minimizing the distance between observed and predicted optimal flux 
distributions was accomplished by minimizing a distance term. Flux ratios can be ! 116!
constrained by adding a row to the S matrix such that:  
V2 – R*V1 = 0 
Where Vn is the flux through reaction n and R is the ratio V2/V1. To minimize 
distance between observed and predicted ratios the equation becomes: 
V2 – R*V1 + D = 0 
V2 – R*V1 – D = 0 
Where D represents distance from the observed ratio and is added as two 
columns to the S matrix (and concomitant rows in the flux vector). Biomass or 
ATP can be constrained to its maximum value and then the flux distribution that 
is closest to observed values can be calculated by running linear optimization 
minimizing D as the objective function. 
 
Comparison of experimental flux ratios to FBA-predicted optima 
 
We first tested whether flux ratios evolve to increase each selective criterion. The 
optimal value of each criterion was compared against the maximum value of the 
criterion when the model was constrained to have the experimentally observed 
flux ratios. Percent optimality, calculated as the constrained criterion divided by 
optimal criterion, was determined for the ancestor and evolved lines.  
 
For the LTEE lines the constrained flux ratios were serine through glycolysis, 
pyruvate through Entner-Doudoroff, oxaloacetate from phosphoenolpyruvate, ! 117!
phosphoenolpyruvate from oxaloacetate, and the pyruvate from malate. The 
ratios were calculated following Fischer and Sauer 2003 [40]; the exact equations 
used are provided in the supplementary material (Supplementary Table 4.3). 
Each ratio was constrained by adding a row to the S matrix that defined the 
relationship between relevant fluxes (as described in the first equation of the 
previous section). The ratio inferred for pyruvate from malate was treated either 
as an absolute constraint or a lower bound but because all optimality criteria 
push this value towards 0 the results were equivalent. 
 
To propagate uncertainty in glucose uptake, acetate excretion and flux ratios for 
the LTEE isolates, separate calculations of properties such as BM/S were made 
for each of 3 biological replicates, which themselves represented the average of 3 
technical replicates. The mean and standard error for optimality metrics was 
calculated for each strain from the biological replicates. 
 
Flux constraints for lactate and knockout data sets were implemented as upper 
and lower bounds, because reported flux ratios were relative to substrate uptake 
rather than other internal fluxes. Lactate adaptation lines were constrained to 
have flux ratios ± 5% of the values reported in Hua et al 2007 [28]. Gene 
knockout lines were constrained with the flux ratios and errors reported in Fong 
et al, 2006 [20].  
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To determine whether strains evolved towards predicted optimal intracellular 
physiologies we used a standardized metric to ask if evolved lines were closer to 
an optimal solution than the ancestor. This distance metric was calculated as: 
log(DEO/DAO) 
where DEO was the distance of the evolved flux ratios from the closest optimal 
solution, and DAO was the distance of the ancestor from its closest optimal 
solution. Distances were calculated as Euclidean distance between the flux ratios 
observed in each data set and those predicted. It should be noted that because 
optimal flux ratios change with substrate uptake the ancestral and evolved 
optima were different points. The metric is 0 if the evolved isolate distance has 
not changed relative to the ancestor, increasingly positive as the evolved strain 
moves nearer an optimum, and increasingly negative as it moves further away. 
 
Pareto optimality 
 
A Pareto optimal surface was calculated for each line by constraining the 
substrate uptake rate and then doing a nested grid search [15]. A grid search 
across the range of feasible biomass values was executed. At each value of 
biomass a grid search of ATP yields was carried out and the sum of fluxes was 
subsequently minimized at every interval. Conservatively, for each isolate we 
then determined the closest possible position to its optimal surface given the 
observed constraints. Distance between the isolate and the Pareto optimal surface ! 119!
was calculated from the difference in standardized criteria.  
 
Statistical tests 
 
The normality assumption for physiological measurements for the LTEE 
populations and optimality metrics for all data sets were checked with the 
Shapiro-Wilk test on the residuals of the linear model fitting the metric against 
strains. In all but one case the null hypothesis that the distribution was normal 
could not be rejected at p < 0.05. The % optimality for the LTEE lines with ATP/S 
as the optimality criterion was not normally distributed. Q-Q plots are presented 
in the supplementary material (Figures S2 and S3). 
 
For the LTEE lines ancestral versus evolved values were compared with two-
sided, two sample T-tests assuming equal variance. For the non-normal ATP/S 
comparison a Mann-Whitney Wilcoxon Rank Sum Test was used instead. For the 
lactate populations only a single value was available for the ancestor so two-sided, 
one-sample T-tests were performed testing against the ancestral value as the 
mean. 
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Supplementary Material 
Supplementary Table 3.1: List of Lenski LTEE isolates used. 
    20,000 generation strains            50,000 generation strains 
 A-1   REL8593   A-1   REL11330 
 A-2L   REL8594   A-2L (Large- A clone)   REL11333 
      A-2S (Small- C clone)   REL11335 
 A-3   REL8595   A-3   REL11364 
 A-4   REL8596   A-4   REL11336 
 A-5   REL8597   A-5   REL11339 
 A-6   REL8598   A-6   REL11389 
 A+1   REL9282   A+1   REL11392 
 A+2   REL8601   A+2   REL11342 
 A+3   REL8602   A+3   REL 11345 
 A+4   REL8603   A+4   REL11348 
 A+5   REL8604   A+5   REL11367 
A+6   REL8605   A+6   REL11370 
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Supplementary Table 3.2: Reactions predicted by FBA as necessary for optimal 
growth on substrates. These are the reactions used to compare substrate differences 
with FBA. The substrates for which the reactions are necessary are listed, as well as the 
percent of optimal growth that is possible without the reactions and related genes. 
Substrate  Reaction name 
% 
optimality 
without 
reaction  Necessary genes 
fumarate 
Fumarate transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
fumarate  malic enzyme NADP  98.9   maeB  
fumarate  phosphoenolpyruvate carboxykinase  98.0   pckA  
melibiose  galactokinase  0.0   galK wcaK  
melibiose  a galactosidase melibiose  0.0   melA  
melibiose  melibiose transport in via symport periplasm  0.0   melB  
melibiose 
melibiose transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
melibiose  phosphoglucomutase  94.8   pgm yqaB  
melibiose  pyruvate kinase  96.8   pykF pykA  
melibiose 
UDPglucose hexose 1 phosphate 
uridylyltransferase  0.0   galT  
acetate  Isocitrate lyase  0.0   aceA  
acetate  phosphoenolpyruvate carboxykinase  96.9   pckA  
D-alanine 
D Alanine transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
D-alanine  Isocitrate lyase  97.4   aceA  
D-alanine  phosphoenolpyruvate synthase  96.4   ppsA  
L-proline 
iron Fe2 transport out via proton antiport 
periplasm  0.0   yiiP  
L-proline  Fe III reduction  79.3   fre  
L-proline  1 pyrroline 5 carboxylate dehydrogenase  0.0   putA  
L-proline  phosphoenolpyruvate carboxykinase  95.7   pckA  
L-proline  Proline dehydrogenase  0.0   putA  
L-proline 
L proline transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
L-aspartate 
L aspartate transport in via proton symport 
periplasm  97.6   gltP  
L-aspartate 
L aspartate transport via diffusion 
extracellular to periplasm  0.0 
 phoE ompF ompN 
ompC  
L-aspartate  phosphoenolpyruvate carboxykinase  98.0   pckA  
mucic acid  galactarate dehydratase  0.0   garD  Supplementary,Table,3.2,,Continued,
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mucic acid 
D galactarate transport via proton symport 
reversible periplasm  0.0   gudP garP  
mucic acid 
D galactarte transport via diffusion 
extracellular to periplasm  0.0 
 phoE ompF ompN 
ompC  
mucic acid  5 dehydro 4 deoxyglucarate aldolase  0.0   garL  
mucic acid  pyruvate kinase  96.8   pykF pykA  
L-malate 
Malate transport via proton symport 2 H  
periplasm  97.5   dctA  
L-malate 
Malate transport via diffusion extracellular to 
periplasm  0.0 
 phoE ompF ompN 
ompC  
L-malate  malic enzyme NADP  98.9   maeB  
L-malate  phosphoenolpyruvate carboxykinase  98.0   pckA  
D-ribose  pyruvate kinase  93.8   pykF pykA  
D-ribose  ribokinase  0.0   rbsK  
D-ribose  D ribose transport via ABC system periplasm  0.0 
 rbsD rbsA rbsC rbsB 
alsC alsA alsB ytfQ ytfT 
yjfF ytfR  
D-ribose 
ribose transport via diffusion extracellular to 
periplasm  0.0 
 phoE ompF ompN 
ompC  
glucose 
3 hydroxyacyl acyl carrier protein dehydratase 
n C100  0.0   fabZ fabA  
glucose 
3 hydroxyacyl acyl carrier protein dehydratase 
n C121  0.0   fabZ fabA  
glucose 
3 hydroxyacyl acyl carrier protein dehydratase 
n C141  0.0   fabZ fabA  
glucose 
3 hydroxyacyl acyl carrier protein dehydratase 
n C161  0.0   fabZ fabA  
glucose 
3 hydroxyacyl acyl carrier protein dehydratase 
n C40  0.0   fabZ fabA  
glucose 
3 hydroxyacyl acyl carrier protein dehydratase 
n C60  0.0   fabZ fabA  
glucose 
3 hydroxyacyl acyl carrier protein dehydratase 
n C80  0.0   fabZ fabA  
glucose 
3 oxoacyl acyl carrier protein reductase n 
C100  0.0   fabG  
glucose  3 oxoacyl acyl carrier protein reductase n C121  0.0   fabG  
glucose 
3 oxoacyl acyl carrier protein reductase n 
C140  0.0   fabG  
glucose  3 oxoacyl acyl carrier protein reductase n C141  0.0   fabG  
glucose  3 oxoacyl acyl carrier protein reductase n C161  0.0   fabG  
glucose  3 oxoacyl acyl carrier protein reductase n C40  0.0   fabG  
glucose  3 oxoacyl acyl carrier protein reductase n C60  0.0   fabG  
glucose  3 oxoacyl acyl carrier protein reductase n C80  0.0   fabG  
glucose  3 oxoacyl acyl carrier protein synthase n C100  0.0   fabF fabB  
glucose  3 oxoacyl acyl carrier protein synthase n C121  0.0   fabB  Supplementary,Table,3.2,,Continued,
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glucose  3 oxoacyl acyl carrier protein synthase n C140  0.0   fabF fabB  
glucose  3 oxoacyl acyl carrier protein synthase n C141  0.0   fabB  
glucose  3 oxoacyl acyl carrier protein synthase n C161  0.0   fabB  
glucose  3 oxoacyl acyl carrier protein synthase n C60  0.0   fabF fabB  
glucose  3 oxoacyl acyl carrier protein synthase n C80  0.0   fabF fabB  
glucose  arabinose 5 phosphate isomerase  0.0   gutQ yrbH  
glucose  acetyl CoA carboxylase  0.0   accA accD accB accC  
glucose  acetylglutamate kinase  0.0   argB  
glucose  N acetylglutamate synthase  0.0   argA  
glucose  2 aceto 2 hydroxybutanoate synthase  0.0   ilvI ilvH ilvN ilvB  
glucose  acetolactate synthase  0.0   ilvI ilvH ilvN ilvB  
glucose  acetylornithine deacetylase  0.0   argE  
glucose  aconitase half reaction A Citrate hydro lyase  0.0   acnB acnA  
glucose 
aconitase half reaction B Isocitrate hydro 
lyase  0.0   acnB acnA  
glucose  4 aminobenzoate synthase  0.0   pabC  
glucose  4 amino 4 deoxychorismate synthase  0.0   pabB pabA  
glucose  adenylyl sulfate kinase  0.0   cysC  
glucose  adenylsuccinate lyase  0.0   purB  
glucose  adenylosuccinate lyase  0.0   purB  
glucose  adenylosuccinate synthase  0.0   purA  
glucose 
1 hexadecanoyl sn glycerol 3 phosphate O 
acyltransferase n C160  0.0   plsC  
glucose 
1 hexadec 7 enoyl sn glycerol 3 phosphate O 
acyltransferase n C161  0.0   plsC  
glucose  S adenosylhomocysteine nucleosidase  0.0   pfs  
glucose 
phosphoribosylaminoimidazolecarboxamide 
formyltransferase  0.0   purH  
glucose  phosphoribosylaminoimidazole carboxylase  0.0   purK  
glucose  D alanine D alanine ligase reversible  0.0   ddlB ddlA  
glucose  alanine racemase  0.0   dadX alr  
glucose 
4 amino 2 methyl 5 phosphomethylpyrimidine 
synthetase  0.0   thiC  
glucose  anthranilate phosphoribosyltransferase  0.0   trpD  
glucose  anthranilate synthase  0.0   trpD trpE  
glucose 
5 amino 6 5 phosphoribosylamino uracil 
reductase  0.0   ribD  
glucose  argininosuccinate lyase  0.0   argH  
glucose  argininosuccinate synthase  0.0   argG  
glucose  aspartate 1 decarboxylase  0.0   panD  
glucose  aspartate carbamoyltransferase  0.0   pyrI pyrB  Supplementary,Table,3.2,,Continued,
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glucose  aspartate kinase  0.0   thrA metL lysC  
glucose  ATP phosphoribosyltransferase  0.0   hisG  
glucose 
ATP synthase four protons for one ATP  
periplasm  35.9 
 atpC atpD atpG atpA 
atpH atpF atpE atpB 
atpI  
glucose 
calcium Ca2 transport via diffusion 
extracellular to periplasm  0.0 
 phoE ompF ompN 
ompC  
glucose  Carbamate kinase  98.9   yahI arcC yqeA  
glucose 
4 cytidine 5 diphospho 2 C methyl D erythritol 
kinase  0.0   ispE  
glucose  chorismate mutase  0.0   pheA tyrA  
glucose  chorismate synthase  0.0   aroC  
glucose  Chorismate pyruvate lyase  0.0   ubiC  
glucose 
chloride transport out via proton antiport 21  
periplasm  0.0   yadQ ynfJ  
glucose 
chloride Cl 1 transport via diffusion 
extracellular to periplasm  0.0 
 phoE ompF ompN 
ompC  
glucose 
cobalt Co2 transport via diffusion 
extracellular to periplasm  0.0 
 phoE ompF ompN 
ompC  
glucose  cobalt transport in via permease no H  0.0   ygiE corA  
glucose  citrate synthase  0.0   gltA  
glucose  CTP synthase glutamine  0.0   pyrG  
glucose 
copper Cu2 transport via diffusion 
extracellular to periplasm  0.0 
 phoE ompF ompN 
ompC  
glucose  copper transport in via permease no H  0.0   ygiE  
glucose  cysteine synthase  0.0   cysK cysM  
glucose  cystathionine b lyase  0.0   malY metC  
glucose 
cytochrome oxidase bo3 ubiquinol 8 4 protons  
periplasm  80.9   cyoD cyoC cyoB cyoA  
glucose  diaminopimelate decarboxylase  0.0   lysA  
glucose  diaminopimelate epimerase  0.0   dapF  
glucose  CDP diacylglycerol synthetase n C160  0.0   cdsA  
glucose  CDP diacylglycerol synthetase n C161  0.0   cdsA  
glucose 
3 4 Dihydroxy 2 butanone 4 phosphate 
synthase  0.0   ribB  
glucose 
3 deoxy D arabino heptulosonate 7 phosphate 
synthetase  0.0   aroG aroH aroF  
glucose 
dihydroxy acid dehydratase 2 3 dihydroxy 3 
methylbutanoate  0.0   ilvD  
glucose 
Dihydroxy acid dehydratase 2 3 dihydroxy 3 
methylpentanoate  0.0   ilvD  
glucose  dihydrodipicolinate reductase NADPH  0.0   dapB  
glucose  dihydrodipicolinate synthase  0.0   dapA  Supplementary,Table,3.2,,Continued,
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glucose  dihydrofolate reductase  0.0   folA ydgB  
glucose  dihydrofolate synthase  0.0   folC  
glucose  dihydroneopterin aldolase  0.0   ygiG  
glucose 
diaminohydroxyphosphoribosylaminopryrimi
dine deaminase 25drapp  0.0   ribD  
glucose  dihydropteroate synthase  0.0   folP  
glucose 
4 5 dihydroxy 2 3 pentanedione cyclization 
spontaneous  0.0   thrL  
glucose  3 dehydroquinate synthase  0.0   aroB  
glucose  3 dehydroquinate dehydratase irreversible  0.0   aroD  
glucose  dimethylallyltranstransferase  0.0   ispA  
glucose 
Dihydroneopterin triphosphate 
pyrophosphatase  0.0   mutT ntpA  
glucose  dephospho CoA kinase  0.0   yacE  
glucose  2 dehydropantoate 2 reductase  0.0   apbA ilvC  
glucose  dTMP kinase  0.0   tmk  
glucose  1 deoxy D xylulose reductoisomerase  0.0   ispC  
glucose  1 deoxy D xylulose 5 phosphate synthase  0.0   dxs  
glucose  Erythrose 4 phosphate dehydrogenase  0.0   epd  
glucose  enolase  80.4   eno  
glucose  fructose bisphosphate aldolase  98.4   ydjI fbaB fbaA  
glucose  Ferrochelatase  0.0   hemH  
glucose  FMN adenylyltransferase  0.0   ribF  
glucose  fumarase  92.3   fumC fumA fumB  
glucose  glucosamine 1 phosphate N acetyltransferase  0.0   glmU  
glucose  glutamate 1 semialdehyde aminotransferase  0.0   hemL  
glucose  glycerol 3 phosphate acyltransferase C160  0.0   plsB  
glucose  glycerol 3 phosphate acyltransferase C161  0.0   plsB  
glucose 
L glutamate 5 semialdehyde dehydratase 
spontaneous  0.0   thrL  
glucose  glucose 6 phosphate dehydrogenase  98.0   zwf  
glucose  glyceraldehyde 3 phosphate dehydrogenase  68.8   gapA  
glucose  Glycolaldehyde dehydrogenase  0.0   aldA  
glucose  glutamine fructose 6 phosphate transaminase  0.0   glmS  
glucose  glycine hydroxymethyltransferase reversible  96.9   glyA  
glucose  guanylate kinase GMPATP  0.0   gmk  
glucose 
D glucose transport via PEPPyr PTS 
periplasm  97.4 
 ptsG malX manX 
manY manZ ptsH ptsI 
crr  
glucose 
D glucoseMaltotriose transport via diffusion 
extracellular to periplasm irreversible  0.0   lamB  Supplementary,Table,3.2,,Continued,
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glucose  glutamine synthetase  0.0   ycjK glnA  
glucose 
glutamine phosphoribosyldiphosphate 
amidotransferase  0.0   purF  
glucose  glutamyl tRNA reductase  0.0   hemA  
glucose  Glutamyl tRNA synthetase  0.0   gltX  
glucose  GMP synthase  0.0   guaA  
glucose  phosphogluconate dehydrogenase  98.0   gnd  
glucose  geranyltranstransferase  0.0   ispA  
glucose  GTP cyclohydrolase I  0.0   folE  
glucose  GTP cyclohydrolase II 25drapp  0.0   ribA  
glucose  Hydroxybenzoate octaprenyltransferase  0.0   ubiA  
glucose  HCO3 equilibration reaction  0.0   yadF cynT  
glucose  histidinol dehydrogenase  0.0   hisD  
glucose  histidinol phosphatase  0.0   hisB  
glucose  hydroxymethylbilane synthase  0.0   hemC  
glucose 
6 hydroxymethyl dihydropterin 
pyrophosphokinase  0.0   folK  
glucose  homoserine kinase  0.0   thrB  
glucose  homoserine O succinyltransferase  0.0   metA  
glucose  histidinol phosphate transaminase  0.0   hisC  
glucose  isocitrate dehydrogenase NADP  0.0   icdA  
glucose  Imidazole glycerol 3 phosphate synthase  0.0   hisH hisF  
glucose  imidazoleglycerol phosphate dehydratase  0.0   hisB  
glucose  indole 3 glycerol phosphate synthase  0.0   trpC  
glucose  3 isopropylmalate dehydrogenase  0.0   leuB  
glucose  2 isopropylmalate synthase  0.0   leuA  
glucose 
KDO 2 lipid IV A transport via ABC system 
periplasm  0.0   msbA  
glucose  ketol acid reductoisomerase 2 Acetolactate  0.0   ilvC  
glucose 
3 deoxy manno octulosonate 
cytidylyltransferase  0.0   kdsB  
glucose  3 deoxy manno octulosonate 8 phosphatase  0.0   yrbI  
glucose 
3 deoxy D manno octulosonic acid 8 
phosphate synthase  0.0   kdsA  
glucose 
potassium transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
glucose  leucine transaminase irreversible  0.0   ilvE tyrB  
glucose  Lipid A disaccaride synthase  0.0   lpxB  
glucose  Malonyl CoA ACP transacylase  0.0   fabD acpP  
glucose 
murein crosslinking transpeptidase 1A A2pm 
D ala  periplasm  0.0   ftsI mrcB mrdA mrcA  
glucose  malate dehydrogenase  96.8   mdh  Supplementary,Table,3.2,,Continued,
! 132!
glucose 
2C methyl D erythritol 2 4 cyclodiphosphate 
dehydratase  0.0   ispG  
glucose 
2 C methyl D erythritol 2 4 cyclodiphosphate 
synthase  0.0   ispF  
glucose 
2 C methyl D erythritol 4 phosphate 
cytidylyltransferase  0.0   ispD  
glucose  methionine adenosyltransferase  0.0   metK  
glucose  methionine synthase  0.0   metE metH  
glucose 
magnesium Mg2 transport via diffusion 
extracellular to periplasm  0.0 
 phoE ompF ompN 
ompC  
glucose 
Manganese Mn2 transport via diffusion 
extracellular to periplasm  0.0 
 phoE ompF ompN 
ompC  
glucose  3 deoxy D manno octulosonic acid transferase  0.0   kdtA  
glucose  3 deoxy D manno octulosonic acid transferase  0.0   kdtA  
glucose 
molybdate transport via ABC system 
periplasm  0.0 
 modA modB modC 
cysA cysW cysU cysP 
sbp  
glucose 
molybdate transport via diffusion 
extracellular to periplasm  0.0 
 phoE ompF ompN 
ompC  
glucose 
3 methyl 2 oxobutanoate 
hydroxymethyltransferase  0.0   panB  
glucose  murein polymerizing transglycosylase  0.0   mrcB pbpC mrcA  
glucose  methenyltetrahydrofolate cyclohydrolase  97.4   folD  
glucose 
methylenetetrahydrofolate dehydrogenase 
NADP  97.4   folD  
glucose 
5 10 methylenetetrahydrofolate reductase 
NADH  0.0   metF  
glucose  NAD kinase  0.0   yfjB  
glucose  NAD synthase nh3  0.0   nadE  
glucose  nucleoside diphosphate kinase ATPUDP  0.0   adk ndk  
glucose  nucleoside diphosphate kinase ATPdTDP  0.0   adk ndk  
glucose 
ammonia transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
glucose  ammonia reversible transport periplasm  0.0   amtB thrL  
glucose  nicotinate nucleotide adenylyltransferase  0.0   nadD  
glucose 
nicotinate nucleotide diphosphorylase 
carboxylating  0.0   nadC  
glucose 
oxygen transport via diffusion extracellular to 
periplasm  21.2 
 phoE ompF ompN 
ompC  
glucose  o2 transport via diffusion periplasm  21.2   thrL  
glucose  ornithine carbamoyltransferase  0.0   argF argI  
glucose  Octaprenyl pyrophosphate synthase  0.0   ispB  
glucose 
O Phospho 4 hydroxy L threonine2 
oxoglutarate aminotransferase  0.0   serC  Supplementary,Table,3.2,,Continued,
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glucose 
2 Oxo 4 methyl 3 carboxypentanoate 
decarboxylation  0.0   leuB  
glucose  orotidine 5 phosphate decarboxylase  0.0   pyrF  
glucose  Octaprenyl hydroxybenzoate decarboxylase  0.0   ubiX ubiD  
glucose  pyrroline 5 carboxylate reductase  0.0   proC  
glucose  pantothenate synthase  0.0   panC  
glucose 
phospho N acetylmuramoyl pentapeptide 
transferase meso 2 6 diaminopimelate  0.0   mraY  
glucose  pyruvate dehydrogenase  96.2   aceE aceF lpdA  
glucose  Pyridoxine 5 phosphate synthase  0.0   pdxA pdxJ  
glucose 
phosphatidylethanolamine transport via ABC 
system n C160 periplasm  0.0   msbA  
glucose 
phosphatidylethanolamine transport via ABC 
system n C161 periplasm  0.0   msbA  
glucose  Erythronate 4 phosphate 4per dehydrogenase  0.0   pdxB  
glucose  phosphofructokinase  98.4   pfkB pfkA  
glucose  phosphoglycerate dehydrogenase  95.3   serA  
glucose  glucose 6 phosphate isomerase  98.6   pgi  
glucose  6 phosphogluconolactonase  98.0   ybhE  
glucose 
phosphate transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
glucose  phosphomethylpyrimidine kinase  0.0   thiD  
glucose  pantothenate kinase  0.0   coaA  
glucose  porphobilinogen synthase  0.0   hemB  
glucose  phosphopantothenoylcysteine decarboxylase  0.0   dfp  
glucose  phosphopantothenate cysteine ligase  0.0   dfp  
glucose  prephenate dehydrogenase  0.0   tyrA  
glucose  prephenate dehydratase  0.0   pheA  
glucose  phosphoribosylglycinamide synthase  0.0   purD  
glucose  phosphoribosylaminoimidazole synthase  0.0   purM  
glucose 
phosphoribosylanthranilate isomerase 
irreversible  0.0   trpC  
glucose  phosphoribosyl AMP cyclohydrolase  0.0   hisI  
glucose 
phosphoribosylaminoimidazolesuccinocarbox
amide synthase  0.0   purC  
glucose  phosphoribosyl ATP pyrophosphatase  0.0   hisI  
glucose  phosphoribosylformylglycinamidine synthase  0.0   purL  
glucose 
1 5 phosphoribosyl 5 5 phosphoribosylamino 
methylideneamino imidazole 4 carboxamide 
isomerase  0.0   hisA  
glucose  3 phosphoshikimate 1 carboxyvinyltransferase  0.0   aroA  
glucose  Phosphatidylserine decarboxylase n C160  0.0   psd  Supplementary,Table,3.2,,Continued,
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glucose  Phosphatidylserine decarboxylase n C161  0.0   psd  
glucose  phosphoserine transaminase  95.3   serC  
glucose  phosphoserine phosphatase L serine  95.3   serB  
glucose  Phosphatidylserine syntase n C160  0.0   pssA  
glucose  Phosphatidylserine syntase n C161  0.0   pssA  
glucose  pantetheine phosphate adenylyltransferase  0.0   coaD  
glucose  quinolinate synthase  0.0   nadA  
glucose  riboflavin kinase  0.0   ribF  
glucose  riboflavin synthase  0.0   ribC  
glucose  riboflavin synthase  0.0   ribE  
glucose  S ribosylhomocysteine cleavage enzyme  0.0   ygaG  
glucose  ribulose 5 phosphate 3 epimerase  98.4   rpe sgcE  
glucose  Sulfate adenyltransferase  0.0   cysN cysD  
glucose  succinyl diaminopimelate desuccinylase  0.0   dapE  
glucose  serine O acetyltransferase  0.0   cysE  
glucose  sirohydrochlorin dehydrogenase NAD  0.0   cysG  
glucose  sirohydrochlorin ferrochetalase  0.0   cysG  
glucose  shikimate dehydrogenase  0.0   ydiB aroE  
glucose  shikimate kinase  0.0   aroL aroK  
glucose  O succinylhomoserine lyase L cysteine  0.0   metB  
glucose 
sulfate transport via diffusion extracellular to 
periplasm  0.0 
 phoE ompF ompN 
ompC  
glucose  succinate dehydrogenase irreversible  95.5   sdhC sdhD sdhA sdhB  
glucose  sulfite reductase NADPH2  0.0   cysI cysJ  
glucose  sulfate transport via ABC system periplasm  0.0 
 modA modB modC 
cysA cysW cysU cysP 
sbp  
glucose  trans 2 decenoyl ACP isomerase  0.0   fabA  
glucose  transaldolase  98.2   talB talA  
glucose  Tetraacyldisaccharide 4 kinase  0.0   lpxK  
glucose  tetrahydrodipicolinate succinylase  0.0   dapD  
glucose  L threonine deaminase  0.0   sdaA sdaB tdcB ilvA  
glucose  threonine synthase  0.0   thrC  
glucose  thiazole phosphate synthesis  0.0 
 thiI iscS thiH thiG thiF 
thiS  
glucose  transketolase  98.6   tktB tktA  
glucose  transketolase  98.6   tktB tktA  
glucose  thymidylate synthase  0.0   thyA  
glucose  thiamine phosphate kinase  0.0   thiL  Supplementary,Table,3.2,,Continued,
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glucose  thiamine phosphate diphosphorylase  0.0   thiE  
glucose  triose phosphate isomerase  91.5   tpiA  
glucose 
UDP 3 O 3 hydroxymyristoyl glucosamine 
acyltransferase  0.0   lpxD  
glucose 
UDP N acetylmuramoyl L alanyl D glutamyl 
meso 2 6 diaminopimelate synthetase  0.0   murE  
glucose  UDP N acetylglucosamine acyltransferase  0.0   lpxA acpP  
glucose 
UDP N acetylglucosamine 1 
carboxyvinyltransferase  0.0   murA  
glucose  UDP N acetylglucosamine diphosphorylase  0.0   glmU  
glucose 
UDP N acetylglucosamine N acetylmuramyl 
pentapeptide pyrophosphoryl undecaprenol N 
acetylglucosamine transferase  0.0   murG  
glucose 
UDP N acetylmuramoyl L alanyl D glutamate 
synthetase  0.0   murD  
glucose  UDP N acetylmuramoyl L alanine synthetase  0.0   murC  
glucose 
UDP N acetylenolpyruvoylglucosamine 
reductase  0.0   murB  
glucose  undecaprenyl diphosphatase  0.0   ybjG pgpB bacA  
glucose  Undecaprenyl diphosphate synthase  0.0   uppS  
glucose 
UDP N acetylmuramoyl L alanyl D glutamyl 
meso 2 6 diaminopimeloyl D alanyl D alanine 
synthetase  0.0   murF  
glucose  UDP 3 O acetylglucosamine deacetylase  0.0   lpxC  
glucose  UMP kinase  0.0   pyrH cmk  
glucose  uroporphyrinogen methyltransferase  0.0   cysG hemX  
glucose  uroporphyrinogen III synthase  0.0   hemD  
glucose 
uroporphyrinogen decarboxylase 
uroporphyrinogen III  0.0   hemE  
glucose  UDP sugar hydrolase  0.0   ybbF  
glucose 
zinc Zn2 transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
uridine  Uracil exchange  60.7    
uridine  pyruvate kinase  98.2   pykF pykA  
uridine  pyrimidine nucleoside phosphorylase uracil  95.1   udp  
uridine 
uridine transport via diffusion extracellular to 
periplasm  0.0   tsx  
D-sorbitol  sorbitol 6 phosphate dehydrogenase  0.0   srlD  
D-sorbitol 
D sorbitol transport via PEPPyr PTS 
periplasm  0.0   ptsH ptsI srlA srlE srlB  
D-sorbitol 
D sorbitol transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
fructose 
Fructose transport via PEPPyr PTS f6p 
generating  periplasm  97.6 
 manX manY manZ 
ptsH ptsI  Supplementary,Table,3.2,,Continued,
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fructose 
D fructose transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
L-serine  Isocitrate lyase  98.7   aceA  
L-serine  phosphoenolpyruvate synthase  98.6   ppsA  
L-serine 
L serine transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
trehalose 
trehalose transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
D-serine  D serine dehydrogenase  96.4   ydfG  
D-serine 
D serine transport in via proton symport 
periplasm  0.0   cycA  
D-serine 
D serine transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
D-serine  Isocitrate lyase  98.7   aceA  
D-serine  phosphoenolpyruvate synthase  98.6   ppsA  
galactose  galactokinase  0.0   galK wcaK  
galactose 
D galactose transport in via proton symport 
periplasm  92.0   galP  
galactose 
D galactose transport via diffusion 
extracellular to periplasm  0.0 
 phoE ompF ompN 
ompC  
galactose  phosphoglucomutase  89.4   pgm yqaB  
galactose  pyruvate kinase  96.7   pykF pykA  
galactose 
UDPglucose hexose 1 phosphate 
uridylyltransferase  0.0   galT  
lactose  galactokinase  51.2   galK wcaK  
lactose 
Lactose transport via diffusion extracellular to 
periplasm  0.0 
 phoE ompF ompN 
ompC  
lactose  phosphoglucomutase  94.8   pgm yqaB  
lactose 
UDPglucose hexose 1 phosphate 
uridylyltransferase  51.2   galT  
gluconate 
D gluconate transport via proton symport 
reversible periplasm  0.0   gntT idnT gntP gntU  
gluconate 
D gluconate transport via diffusion 
extracellular to periplasm  0.0 
 phoE ompF ompN 
ompC  
gluconate  gluconokinase  0.0   gntK idnK  
gluconate  pyruvate kinase  95.3   pykF pykA  
mannose  mannose 6 phosphate isomerase  0.0   manA  
mannose 
D mannose transport via PEPPyr PTS 
periplasm  0.0 
 manX manY manZ 
ptsH ptsI  
mannose 
D mannose transport via diffusion 
extracellular to periplasm  0.0 
 phoE ompF ompN 
ompC  
maltose  maltose transport via ABC system periplasm  0.0   malG malF malE malK  Supplementary,Table,3.2,,Continued,
! 137!
maltose 
maltoseMaltotriose transport via diffusion 
extracellular to periplasm irreversible  0.0   lamB  
maltose  phosphoglucomutase  94.8   pgm yqaB  
maltose  pyruvate kinase  96.9   pykF pykA  
lactate  Isocitrate lyase  98.8   aceA  
lactate 
L lactate reversible transport via proton 
symport periplasm  0.0   yghK lldP  
lactate 
L lactate transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
lactate  phosphoenolpyruvate synthase  96.3   ppsA  
lactate  NAD P transhydrogenase periplasm  98.3   pntB pntA  
succinate  malic enzyme NADP  95.2   maeB  
succinate  phosphoenolpyruvate carboxykinase  95.5   pckA  
succinate 
succinate transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
citrate 
Citrate transport via succinate antiport 
periplasm  0.0   citT  
citrate 
citrate transport via diffusion extracellular to 
periplasm  0.0 
 phoE ompF ompN 
ompC  
citrate  phosphoenolpyruvate carboxykinase  98.0   pckA  
L-alanine 
L alanine transport via diffusion extracellular 
to periplasm  0.0 
 phoE ompF ompN 
ompC  
L-alanine  Isocitrate lyase  97.4   aceA  
L-alanine  phosphoenolpyruvate synthase  96.4   ppsA  
 
 
 
 
 
 
 
 ,
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Supplementary Table 3.3: Reactions that are not predicted to be shared between the 
metabolism of glucose and alternative substrates, determining the Hamming distance 
between substrates for FBA comparisons.   
Substrate  Reaction Name (reaction not in common with glucose utilization) 
succinate  glucose 6 phosphate dehydrogenase 
succinate  D glucose transport via PEPPyr PTS periplasm 
succinate  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
succinate  phosphogluconate dehydrogenase 
succinate  malic enzyme NADP 
succinate  phosphofructokinase 
succinate  glucose 6 phosphate isomerase 
succinate  6 phosphogluconolactonase 
succinate  phosphoenolpyruvate carboxykinase 
succinate  succinate transport via diffusion extracellular to periplasm 
D-serine  D serine dehydrogenase 
D-serine  D serine transport in via proton symport periplasm 
D-serine  D serine transport via diffusion extracellular to periplasm 
D-serine  glucose 6 phosphate dehydrogenase 
D-serine  D glucose transport via PEPPyr PTS periplasm 
D-serine  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
D-serine  phosphogluconate dehydrogenase 
D-serine  Isocitrate lyase 
D-serine  phosphofructokinase 
D-serine  phosphoglycerate dehydrogenase 
D-serine  glucose 6 phosphate isomerase 
D-serine  6 phosphogluconolactonase 
D-serine  phosphoenolpyruvate synthase 
D-serine  phosphoserine transaminase 
D-serine  phosphoserine phosphatase L serine 
L-serine  glucose 6 phosphate dehydrogenase 
L-serine  D glucose transport via PEPPyr PTS periplasm 
L-serine  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
L-serine  phosphogluconate dehydrogenase 
L-serine  Isocitrate lyase 
L-serine  phosphofructokinase 
L-serine  phosphoglycerate dehydrogenase 
L-serine  glucose 6 phosphate isomerase 
L-serine  6 phosphogluconolactonase 
L-serine  phosphoenolpyruvate synthase Supplementary,Table,3.3,,continued,
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L-serine  phosphoserine transaminase 
L-serine  phosphoserine phosphatase L serine 
L-serine  L serine transport via diffusion extracellular to periplasm 
acetate  glucose 6 phosphate dehydrogenase 
acetate  D glucose transport via PEPPyr PTS periplasm 
acetate  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
acetate  phosphogluconate dehydrogenase 
acetate  Isocitrate lyase 
acetate  pyruvate dehydrogenase 
acetate  phosphofructokinase 
acetate  glucose 6 phosphate isomerase 
acetate  6 phosphogluconolactonase 
acetate  phosphoenolpyruvate carboxykinase 
uridine  aspartate carbamoyltransferase 
uridine  Acetate exchange 
uridine  Uracil exchange 
uridine  fructose bisphosphate aldolase 
uridine  D glucose transport via PEPPyr PTS periplasm 
uridine  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
uridine  orotidine 5 phosphate decarboxylase 
uridine  phosphofructokinase 
uridine  pyruvate kinase 
uridine  pyrimidine nucleoside phosphorylase uracil 
uridine  uridine transport via diffusion extracellular to periplasm 
L-malate  Acetate exchange 
L-malate  glucose 6 phosphate dehydrogenase 
L-malate  D glucose transport via PEPPyr PTS periplasm 
L-malate  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
L-malate  phosphogluconate dehydrogenase 
L-malate  Malate transport via proton symport 2 H  periplasm 
L-malate  Malate transport via diffusion extracellular to periplasm 
L-malate  malic enzyme NADP 
L-malate  phosphofructokinase 
L-malate  glucose 6 phosphate isomerase 
L-malate  6 phosphogluconolactonase 
L-malate  phosphoenolpyruvate carboxykinase 
L-proline  Acetate exchange 
L-proline  iron Fe2 transport out via proton antiport periplasm 
L-proline  Fe III reduction Supplementary,Table,3.3,,continued,
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L-proline  L glutamate 5 semialdehyde dehydratase spontaneous 
L-proline  glucose 6 phosphate dehydrogenase 
L-proline  D glucose transport via PEPPyr PTS periplasm 
L-proline  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
L-proline  phosphogluconate dehydrogenase 
L-proline  1 pyrroline 5 carboxylate dehydrogenase 
L-proline  pyrroline 5 carboxylate reductase 
L-proline  phosphofructokinase 
L-proline  glucose 6 phosphate isomerase 
L-proline  6 phosphogluconolactonase 
L-proline  phosphoenolpyruvate carboxykinase 
L-proline  Proline dehydrogenase 
L-proline  L proline transport via diffusion extracellular to periplasm 
fumarate  Acetate exchange 
fumarate  Fumarate transport via diffusion extracellular to periplasm 
fumarate  glucose 6 phosphate dehydrogenase 
fumarate  D glucose transport via PEPPyr PTS periplasm 
fumarate  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
fumarate  phosphogluconate dehydrogenase 
fumarate  malic enzyme NADP 
fumarate  phosphofructokinase 
fumarate  glucose 6 phosphate isomerase 
fumarate  6 phosphogluconolactonase 
fumarate  phosphoenolpyruvate carboxykinase 
D-ribose  fructose bisphosphate aldolase 
D-ribose  D glucose transport via PEPPyr PTS periplasm 
D-ribose  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
D-ribose  phosphofructokinase 
D-ribose  pyruvate kinase 
D-ribose  ribokinase 
D-ribose  D ribose transport via ABC system periplasm 
D-ribose  ribose transport via diffusion extracellular to periplasm 
mucic acid  Acetate exchange 
mucic acid  glucose 6 phosphate dehydrogenase 
mucic acid  galactarate dehydratase 
mucic acid  D galactarte transport via proton symport reversible periplasm 
mucic acid  D galactarte transport via diffusion extracellular to periplasm 
mucic acid  5 dehydro 4 deoxyglucarate aldolase 
mucic acid  D glucose transport via PEPPyr PTS periplasm Supplementary,Table,3.3,,continued,
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mucic acid  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
mucic acid  phosphogluconate dehydrogenase 
mucic acid  phosphofructokinase 
mucic acid  glucose 6 phosphate isomerase 
mucic acid  6 phosphogluconolactonase 
mucic acid  pyruvate kinase 
D-alanine  D Alanine transport via diffusion extracellular to periplasm 
D-alanine  glucose 6 phosphate dehydrogenase 
D-alanine  D glucose transport via PEPPyr PTS periplasm 
D-alanine  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
D-alanine  phosphogluconate dehydrogenase 
D-alanine  Isocitrate lyase 
D-alanine  phosphofructokinase 
D-alanine  glucose 6 phosphate isomerase 
D-alanine  6 phosphogluconolactonase 
D-alanine  phosphoenolpyruvate synthase 
L-alanine  L alanine transport via diffusion extracellular to periplasm 
L-alanine  glucose 6 phosphate dehydrogenase 
L-alanine  D glucose transport via PEPPyr PTS periplasm 
L-alanine  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
L-alanine  phosphogluconate dehydrogenase 
L-alanine  Isocitrate lyase 
L-alanine  phosphofructokinase 
L-alanine  glucose 6 phosphate isomerase 
L-alanine  6 phosphogluconolactonase 
L-alanine  phosphoenolpyruvate synthase 
L-aspartate  L aspartate transport in via proton symport periplasm 
L-aspartate  L aspartate transport via diffusion extracellular to periplasm 
L-aspartate  Acetate exchange 
L-aspartate  glucose 6 phosphate dehydrogenase 
L-aspartate  D glucose transport via PEPPyr PTS periplasm 
L-aspartate  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
L-aspartate  phosphogluconate dehydrogenase 
L-aspartate  phosphofructokinase 
L-aspartate  glucose 6 phosphate isomerase 
L-aspartate  6 phosphogluconolactonase 
L-aspartate  phosphoenolpyruvate carboxykinase 
D-sorbitol  D glucose transport via PEPPyr PTS periplasm 
D-sorbitol  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible Supplementary,Table,3.3,,continued,
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D-sorbitol  sorbitol 6 phosphate dehydrogenase 
D-sorbitol  D sorbitol transport via PEPPyr PTS periplasm 
D-sorbitol  D sorbitol transport via diffusion extracellular to periplasm 
lactate  glucose 6 phosphate dehydrogenase 
lactate  D glucose transport via PEPPyr PTS periplasm 
lactate  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
lactate  phosphogluconate dehydrogenase 
lactate  Isocitrate lyase 
lactate  L lactate reversible transport via proton symport periplasm 
lactate  L lactate transport via diffusion extracellular to periplasm 
lactate  phosphofructokinase 
lactate  glucose 6 phosphate isomerase 
lactate  6 phosphogluconolactonase 
lactate  phosphoenolpyruvate synthase 
lactate  NAD P transhydrogenase periplasm 
citrate  Citrate transport via succinate antiport periplasm 
citrate  citrate transport via diffusion extracellular to periplasm 
citrate  Acetate exchange 
citrate  glucose 6 phosphate dehydrogenase 
citrate  D glucose transport via PEPPyr PTS periplasm 
citrate  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
citrate  phosphogluconate dehydrogenase 
citrate  phosphofructokinase 
citrate  glucose 6 phosphate isomerase 
citrate  6 phosphogluconolactonase 
citrate  phosphoenolpyruvate carboxykinase 
galactose  fructose bisphosphate aldolase 
galactose  galactokinase 
galactose  D galactose transport in via proton symport periplasm 
galactose  D galactose transport via diffusion extracellular to periplasm 
galactose  D glucose transport via PEPPyr PTS periplasm 
galactose  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
galactose  phosphofructokinase 
galactose  phosphoglucomutase 
galactose  pyruvate kinase 
galactose  UDPglucose hexose 1 phosphate uridylyltransferase 
gluconate  Acetate exchange 
gluconate  fructose bisphosphate aldolase 
gluconate  glucose 6 phosphate dehydrogenase Supplementary,Table,3.3,,continued,
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gluconate  D gluconate transport via proton symport reversible periplasm 
gluconate  D gluconate transport via diffusion extracellular to periplasm 
gluconate  D glucose transport via PEPPyr PTS periplasm 
gluconate  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
gluconate  gluconokinase 
gluconate  phosphofructokinase 
gluconate  glucose 6 phosphate isomerase 
gluconate  6 phosphogluconolactonase 
gluconate  pyruvate kinase 
lactose  fructose bisphosphate aldolase 
lactose  galactokinase 
lactose  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
lactose  Lactose transport via diffusion extracellular to periplasm 
lactose  phosphofructokinase 
lactose  phosphoglucomutase 
lactose  UDPglucose hexose 1 phosphate uridylyltransferase 
mannose  D glucose transport via PEPPyr PTS periplasm 
mannose  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
mannose  mannose 6 phosphate isomerase 
mannose  D mannose transport via PEPPyr PTS periplasm 
mannose  D mannose transport via diffusion extracellular to periplasm 
maltose  fructose bisphosphate aldolase 
maltose  D glucose transport via PEPPyr PTS periplasm 
maltose  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
maltose  maltose transport via ABC system periplasm 
maltose  maltoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
maltose  phosphofructokinase 
maltose  phosphoglucomutase 
maltose  pyruvate kinase 
fructose  Fructose transport via PEPPyr PTS f6p generating  periplasm 
fructose  D fructose transport via diffusion extracellular to periplasm 
fructose  D glucose transport via PEPPyr PTS periplasm 
fructose  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
fructose  phosphofructokinase 
trehalose  D glucose transport via PEPPyr PTS periplasm 
trehalose  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
trehalose  trehalose transport via diffusion extracellular to periplasm 
melibiose  fructose bisphosphate aldolase 
melibiose  galactokinase Supplementary,Table,3.3,,continued,
! 144!
melibiose  a galactosidase melibiose 
melibiose  D glucose transport via PEPPyr PTS periplasm 
melibiose  D glucoseMaltotriose transport via diffusion extracellular to periplasm irreversible 
melibiose  melibiose transport in via symport periplasm 
melibiose  melibiose transport via diffusion extracellular to periplasm 
melibiose  phosphofructokinase 
melibiose  phosphoglucomutase 
melibiose  pyruvate kinase 
melibiose  UDPglucose hexose 1 phosphate uridylyltransferase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ,
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Supplementary Table 3.4: Summary of alternative metrics used to assess the 
difference between substrate utilization using flux balance analysis predictions 
Flux Vector 
Comparison 
Metric 
Sign of 
relationship 
matches 
prediction? 
Significance
?  R2  Description and Notes 
Euclidean 
distance  No  P=0.49  0 
Includes amount of flux per reaction, not 
just reaction use. Coefficient of 
relationship is positive (i.e., in the 
opposite direction predicted). 
1-Correlation  Yes  P=0.91  0 
Includes amount of flux per reaction, not 
just reaction use, and uses one minus the 
Pearson's R coefficient as the metric 
(glucose is a score of 0- perfectly 
correlated with itself) 
Hamming 
distance  No  P=0.26  0.004 
Counts the number of reactions used for 
optimal growth on glucose and not for an 
alternative substrate as well as those 
used for an alternative substrate and not 
for glucose. 
Mutational 
target size  Yes  P=0.15  0.01 
Counts the number of coding nucleotides 
for the genes involved in reactions 
predicted as necessary for optimal 
growth on a carbon source. 
Count of 
unused 
reactions  Yes  P=0.04  0.02 
Unlike Hamming distance, which counts 
reactions used for glucose and not for 
alternative substrates, this only counts 
reactions used for alternative substrates 
and not glucose 
 
 
 
 
 ,
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Supplementary Figure 3.1: Summary of parallel changes observed using Biolog 
assays. Blue shading indicates catabolic function that consistently decayed across the 
parallel populations (statistically significant loss of function for the evolved strains as a 
group compared to ancestor). Red shading represents statistically significant gains of 
function. The number in each cell is the number of populations that significantly lost 
catabolic function on that carbon source relative to the ancestor (P<0.0005). There were 
twelve evolved isolates tested for all timepoints except 50k, for which 13 strains were 
tested (including A-2S). Substrates in green and italicized allowed no growth of the 
ancestor within 48 hours in growth rate assays in DM media.  
 
 
 
 ,
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Supplementary Figure 3.2: Respiration assay for ancestral and evolved strains on 
citrate. Points show biological replicate measurements for different groups of strains. 
The signal for the Cit+ A-3 50k isolate is statistically indistinguishable from other 50k 
isolates. 
 
 
 
 
 
 
 ,
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Supplementary Figure 3.3: Histogram showing less parallelism of metabolic 
declines in growth rate than respiration. The x axis indicates the number of strains that 
exhibited a metabolic decline on a substrate. The grey bars are observed metabolic 
decreases, the black line is the mean observed number of decreases, and the red outline 
is the null distribution for a single observation given random increases and decreases. 
Growth rate changes for 20k (A) and 50k (B) isolates did not show the same degree of 
parallelism as cellular respiration declines at 20k (C) and 50k (D). The substrates 
considered were all those for which growth rate and respiration data were both available 
and for which the ancestor exhibited growth or respiration- necessary for the evolved 
strains to demonstrate reductions. These substrates were: acetate, D-alanine, D-
saccharic acid, D-serine, D-sorbitol, galactose, L-alanine, L-proline, L-serine, lactate, 
lactose, maltose, mannose, melibiose, mono-methyl succinate, mucic acid, ribose, and 
trehalose. 
 ,
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Supplementary Figure 3.4: Representative growth curves and fitted growth rates. A) 
Measured growth curves for 50k isolates of A-2L (red), A-1 (black). B) Fitted growth 
rates from the measured growth curves.  
 
 
 
 
 
 
 
 
 
 ,
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Supplementary Figure 4.1: Covariance of fluxes inferred for the LTEE. To 
determine whether there was a significant change in flux ratios between populations of 
the LTEE we ran a MANOVA as described in the text; however, to provide further 
insight into the basis of the significant differences that we observed we present a chart of 
the correlations between all fluxes. A) The value of the correlation and the significance 
are presented on the bottom half of the chart. B) The proportion of variation explained 
by each eigenvector. 
 ,
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Supplementary Figure 4.1, continued 
 
 
 
 
 
 
 
 ,
! 152!
Supplementary Figure 4.2: Normality tests for data associated with the 
LTEE.  Q-Q plots and Shapiro-Wilk values are displayed for growth parameters, and 
flux ratios. Additionally, data is displayed about the normality of % optimality and 
distance for different criteria. ,
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Supplementary Figure 4.3: Normality tests for data associated with the 
lactate strains.  Q-Q plots and Shapiro-Wilk values are displayed for growth 
parameters, and flux ratios. Additionally, data is displayed about the normality of % 
optimality and distance for different criteria. 
 
 
 ,
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Supplementary Figure 4.4: Measures of optimality based upon BM/Σ v or 
ATP/Σ v for all data sets.  (A,B,E,F,I,J) The % optimality of the ancestor (black) and 
evolved isolates (grey); (C,D,G,H,K,L) distance to optimal flux distribution for FBA-
predictions (plotted as log(DEO/DAO)). These were performed based upon BM/Σv 
(A,C,E,G,I,K) or ATP/Σv (B,D,F,H,J,L). The data sets are LTEE (A-D), lactate (E-H), 
and KO (I-L). Error bars for LTEE represent standard errors of three biological 
replicates. 
 
 
 
 
 ,
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Supplementary Figure 4.4, continued 
 
 
 
 
 
 
 
 
 ,
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Supplementary Figure 4.4, continued 
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Supplementary Figure 4.5: Measures of optimality based on maximizing the 
tradeoff between BM, ATP and Σ v for all data sets. The Pareto distance of the 
ancestor (black) and evolved isolates (grey) for LTEE (A), lactate (B), and KO (C). Error 
bars represent standard errors of three biological replicates. 
 
 
 
 
 
 
 
 
 
 
 ,
! 158!
Supplementary Figure 4.6: Implementation of oxygen constraints. Following 
the example of Schuetz et al 2007 [11] we varied the ancestral oxygen uptake rate across 
the range reported in the literature (11.5-14.75 mmol/g hr). Ibarra et al 2002 [24] report 
that the ratio of oxygen to glucose uptake remains largely constant as cells evolve. We 
tested the impact of varying ancestral oxygen/glucose ratio as well as the slope of 
evolutionary change from 0.5 to 1.5. There was no significant difference in the change in 
% optimality for either BM/S (A) or ATP/S (B) across this wide range of parameter 
values. Results are not presented for an ancestral oxygen uptake rate of 11.5 for ATP/S 
because this constraint caused infeasible solutions for several evolved populations.  
Results obtained with the default values used throughout the manuscript, an ancestral 
uptake of 14.75 mmol/g hr and a slope of 1, are highlighted in red. 
 
 
 
 
 
 
 
 
 ,
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Supplementary Figure 4.6, continued 
 
 ,
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Supplementary Figure 4.7: The effect that potential evolution of constraints 
would have on average change in % optimality between ancestor and 
evolved lines. A) Lipid content was altered in evolved lines from 80-120% of the 
default values. B) Maintenance energy in evolved lines was altered from 50-150% of the 
default value of 8.39 mmol/g hr. Analyses for ATP/S are not shown, as setting a lower 
bound on maintenance energy has no effect if ATP production is being maximized. 
Results for simulations run with default (red) and altered (blue) constraints are shown 
for the LTEE set when optimized for either BM/S or ATP/S. Error bars represent 
standard errors between replicate lines. 
 
 
 
 
 
 
 
 
 
 
 ,
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Supplementary Figure 4.7, continued 
 
 
 
 ,
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Supplementary Figure 4.8: Average difference in % optimality between 
ancestor and evolved lines for each data set for each criterion. The criteria 
tested were BM/S (blue), ATP/S (red), BM/Σv (green) and ATP/Σv (purple). Error bars 
represent standard deviations of replicate lines. 
 
 
 
 
 
 
 ,
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Supplementary Table 4.1: Growth parameters for ancestral and evolved 
LTEE isolates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glucose uptake Acetate excretion Growth rate CDW
g/g CDW h
-1 g/g CDW h
-1 h
-1 g/g glucose
Anc REL606 12.83 ± 0.23 3.27 ± 0.75 0.80 ± 0.10 0.36 ± 0.02
A+1 REL11392 13.59 ± 0.87 6.69 ± 0.30 1.09 ± 0.04 0.44 ± 0.02
A+2 REL11342 15.74 ± 2.24 6.69 ± 0.96 1.18 ± 0.03 0.47 ± 0.03
A+3 REL11345 16.43 ± 0.90 4.32 ± 2.86 1.22 ± 0.02 0.46 ± 0.03
A+4 REL11348 15.78 ± 2.49 6.71 ± 0.94 1.18 ± 0.05 0.45 ± 0.03
A+5 REL11367 14.80 ± 2.04 5.64 ± 1.16 1.16 ± 0.07 0.38 ± 0.02
A-1 REL11330 14.49 ± 2.13 3.67 ± 0.65 1.10 ± 0.01 0.43 ± 0.01
A-2 REL11333 16.21 ± 0.22 2.85 ± 2.07 1.29 ± 0.07 0.39 ± 0.02
A-4 REL11336 15.35 ± 1.03 2.92 ± 0.73 0.99 ± 0.06 0.41 ± 0.01
A-5 REL11339 14.22 ± 0.46 6.35 ± 0.87 1.15 ± 0.07 0.43 ± 0.01
A-6 REL11389 14.25 ± 0.67 3.16 ± 1.15 1.19 ± 0.06 0.44 ± 0.01,
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Supplementary Table 4.2: Experimentally determined flux ratios for 
ancestral and evolved LTEE isolates. PEP through PPP is an upper bound (ub); 
PYR from MAL is a lower bound (lb). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Serine through PYR through PEP through OAA from PEP PEP from OAA PYR from
glycolysis ED pathway PPP (ub) MAL (lb)
Anc 0.74 ± 0.01 0.01 ± 0.00 0.27 ± 0.05 0.69 ± 0.05 0.03 ± 0.01 0.01 ± 0.01
A+1 0.67 ± 0.01 0.06 ± 0.01 0.28 ± 0.03 0.69 ± 0.02 0.03 ± 0.01 0.02 ± 0.01
A+2 0.75 ± 0.01 0.05 ± 0.01 0.18 ± 0.03 0.61 ± 0.03 0.04 ± 0.01 0.00 ± 0.01
A+3 0.75 ± 0.01 0.13 ± 0.00 0.14 ± 0.06 0.71 ± 0.05 0.04 ± 0.02 0.03 ± 0.02
A+4 0.73 ± 0.01 0.03 ± 0.00 0.19 ± 0.05 0.59 ± 0.07 0.05 ± 0.01 0.01 ± 0.02
A+5 0.74 ± 0.01 0.03 ± 0.01 0.23 ± 0.02 0.57 ± 0.03 0.03 ± 0.02 0.02 ± 0.02
A-1 0.83 ± 0.01 0.02 ± 0.02 0.14 ± 0.04 0.59 ± 0.02 0.03 ± 0.00 0.02 ± 0.00
A-2 0.70 ± 0.02 0.03 ± 0.02 0.24 ± 0.05 0.80 ± 0.04 0.04 ± 0.01 0.00 ± 0.00
A-4 0.76 ± 0.01 0.05 ± 0.02 0.18 ± 0.03 0.63 ± 0.01 0.03 ± 0.01 0.01 ± 0.01
A-5 0.73 ± 0.01 0.03 ± 0.00 0.22 ± 0.04 0.60 ± 0.01 0.03 ± 0.02 0.02 ± 0.02
A-6 0.72 ± 0.00 0.03 ± 0.01 0.17 ± 0.05 0.58 ± 0.03 0.03 ± 0.01 0.01 ± 0.01,
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Supplementary text 4.1: Equations used to calculate flux ratios for the 
LTEE.  
The notation v(x) represents the flux through reaction x of the iaf1260 genome-scale 
model of metabolism. 
serine through glycolysis 
=2*(v(1006)+v(1043)-v(2246)-
v(2203))/(v(688)+2*(v(1006)+v(1043))+v(2245)+v(2246)); 
pyruvate through Entner-Doudoroff 
=v(688)/(v(688)+v(575)+v(1233)+v(1626)+v(1627)); 
oxaloacetate from phosphoenolpyruvate 
=v(2020)/(v(2020)+v(1622)+v(1623)+v(1624)); 
phosphoenolpyruvate from oxaloacetate =v(2022)/(v(2022)+v(695)); 
pyruvate from malate 
PYR=(v(1626)+v(1627))/((v(1626)+v(1627)+v(575)+v(1233)+v(1626)+v(1627))); 
 